Publications published since 2010 from OUS - Department of Haematology

866 publications found

Publications 2024

1. Brunetti M, Andersen K, Spetalen S, Lenartova A, Osnes LTN, Vålerhaugen H, Heim S, Micci F (2024)
   NUP214 fusion genes in acute leukemias: genetic characterization of rare cases
   Front Oncol, 14, 1371980
   DOI 10.3389/fonc.2024.1371980, PubMed 38571499
2. Dam M, Centanni M, Friberg LE, Centanni D, Karlsson MO, Stensig Lynggaard L, Johannsdottir IM, Wik HS, Malmros J, Vaitkeviciene GE, Griskevicius L, Hallböök H, Jónsson ÓG, Overgaard U, Schmiegelow K, Hansen SN, Heyman M, Albertsen BK (2024)
   Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia
   Leukemia, 38 (4), 712-719
   DOI 10.1038/s41375-024-02153-6, PubMed 38287133
3. Drozd-Sokolowska J, Gras L, Koster L, Martino R, Salas MQ, Salmenniemi U, Zudaire T, Yañez L, Bellido M, Collin M, Kaufmann M, Kozlowski P, Poiré X, Ferra C, Sampol A, Wilson KMO, Cairoli A, Gedde-Dahl T, Deconinck E, Mirabile M, Suarez F, Raj K, Van Gelder M, Yakoub-Agha I, Tournilhac O et al. (2024)
   Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
   Haematologica (in press)
   DOI 10.3324/haematol.2023.284359, PubMed 38205539
4. Enden T (2024)
   Have a pretty radiant day!
   Tidsskr Nor Laegeforen, 144 (2)
   DOI 10.4045/tidsskr.24.0049, PubMed 38349095
5. Enden T (2024)
   [Not Available]
   Tidsskr Nor Laegeforen, 144
   DOI 10.4045/tidsskr.24.0110, PubMed 38506168
6. Flygt H, Söderlund S, Richter J, Saussele S, Koskenvesa P, Stenke L, Mustjoki S, Dimitrijevic A, Stentoft J, Majeed W, Roy L, Wolf D, Dreimane A, Gjertsen BT, Gedde-Dahl T, Ahlstrand E, Markevärn B, Hjorth-Hansen H, Janssen J, Olsson-Strömberg U (2024)
   Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial
   Leukemia, 38 (4), 781-787
   DOI 10.1038/s41375-024-02145-6, PubMed 38278960
7. Flygt H, Söderlund S, Richter J, Saussele S, Koskenvesa P, Stenke L, Mustjoki S, Dimitrijevic A, Stentoft J, Majeed W, Roy L, Wolf D, Dreimane A, Gjertsen BT, Gedde-Dahl T, Ahlstrand E, Markevärn B, Hjorth-Hansen H, Janssen J, Olsson-Strömberg U (2024)
   Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial
   Leukemia, 38 (4), 925
   DOI 10.1038/s41375-024-02184-z, PubMed 38418611
8. Grdinic AG, Radovanovic S, Gleditsch J, Jørgensen CT, Asady E, Pettersen HH, Delibasic B, Ghanima W (2024)
   Developing a machine learning model for bleeding prediction in patients with cancer-associated thrombosis receiving anticoagulation therapy
   J Thromb Haemost, 22 (4), 1094-1104
   DOI 10.1016/j.jtha.2023.12.034, PubMed 38184201
9. Grønvold BL, Ali MM, Myklebust TÅ, Lenartova A, Remberger M, Abrahamsen IW, Tjønnfjord GE, Myhre AE, Fløisand Y, Gedde-Dahl T (2024)
   Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors
   EJHaem, 5 (1), 117-124
   DOI 10.1002/jha2.842, PubMed 38406518
10. Guièze R, Eikema DJ, Koster L, Schetelig J, Sengeloev H, Passweg J, Finke J, Arat M, Broers AEC, Stölzel F, Byrne J, Castilla-Llorente C, Dreger P, Eder M, Gedde-Dahl T, Kröger N, Ribera Santasusana JM, Richardson D, Rambaldi A, Yañez L, Van Gelder M, Drozd-Sokolowska J, Raj K, Yakoub-Agha I, Tournilhac O et al. (2024)
    Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
    Bone Marrow Transplant (in press)
    DOI 10.1038/s41409-024-02256-9, PubMed 38503942
11. Harrison SP, Baumgarten SF, Chollet ME, Stavik B, Bhattacharya A, Almaas R, Sullivan GJ (2024)
    Parenteral nutrition emulsion inhibits CYP3A4 in an iPSC derived liver organoids testing platform
    J Pediatr Gastroenterol Nutr (in press)
    DOI 10.1002/jpn3.12195, PubMed 38529852
12. Haukeland-Parker S, Jervan Ø, Ghanima W, Spruit MA, Holst R, Tavoly M, Gleditsch J, Johannessen HH (2024)
    Physical activity following pulmonary embolism and clinical correlates in selected patients: a cross-sectional study
    Res Pract Thromb Haemost, 8 (2), 102366
    DOI 10.1016/j.rpth.2024.102366, PubMed 38562511
13. Holland P, Istre M, Ali MM, Gedde-Dahl T, Buechner J, Wildhagen M, Brunvoll SH, Horvath S, Matsuyama S, Dahl JA, Stölzel F, Søraas A (2024)
    Epigenetic aging of human blood cells is influenced by the age of the host body
    Aging Cell, e14112 (in press)
    DOI 10.1111/acel.14112, PubMed 38439206
14. Holme PA, Poulsen LH, Tueckmantel C, Maas Enriquez M, Alvarez Román MT, De Cristofaro R (2024)
    Safety and efficacy of damoctocog alfa pegol prophylaxis in patients with severe haemophilia A: Results of an interventional, post-marketing study
    Haemophilia, 30 (2), 388-394
    DOI 10.1111/hae.14930, PubMed 38229269
15. Kakwangire P, Atukunda P, Ngari M, Westerberg AC, Iversen PO, Muhoozi G (2024)
    Long-term effects on depressive symptoms among Ugandan mothers - Findings from a follow-up of a cluster-randomized education trial in a rural low-resource setting
    J Affect Disord, 351, 598-606
    DOI 10.1016/j.jad.2024.01.263, PubMed 38307132
16. Kakwangire P, Muhoozi G, Ngari M, Matovu N, Westerberg AC, Iversen PO, Atukunda P (2024)
    8-Year Follow-up of a Maternal Education Trial in a Low-Resource Setting
    Pediatrics, 153 (4)
    DOI 10.1542/peds.2023-063352, PubMed 38505933
17. Koroma AS, Stephenson KB, Iversen PO, Manary MJ, Hendrixson DT (2024)
    The Effect of Breastfeeding Practices of Undernourished Mothers in Rural Sierra Leone on Infant Growth and Mortality
    Children (Basel), 11 (2)
    DOI 10.3390/children11020233, PubMed 38397345
18. Loke J, Labopin M, Craddock C, Socié G, Gedde-Dahl T, Blaise D, Forcade E, Salmenniemi U, Huynh A, Versluis J, Yakoub-Agha I, Labussière-Wallet H, Maertens J, Passweg J, Bulabois CE, Gabellier L, Mielke S, Castilla-Llorente C, Deconinck E, Brissot E, Nagler A, Ciceri F, Mohty M (2024)
    Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study
    Cancer (in press)
    DOI 10.1002/cncr.35308, PubMed 38581695
19. Lund T, Gundesen MT, Juul Vangsted A, Helleberg C, Haukås E, Silkjær T, Asmussen JT, Manuela Teodorescu E, Amdi Jensen B, Schmidt Slørdahl T, Nahi H, Waage A, Abildgaard N, Schjesvold F, Nordic Myeloma Study Group (2024)
    In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease
    Blood Cancer J, 14 (1), 65
    DOI 10.1038/s41408-024-01046-2, PubMed 38622134
20. Małecka A, Østlie I, Trøen G, Małecki J, Delabie J, Tierens A, Munthe LA, Berentsen S, Tjønnfjord GE (2024)
    Gene expression analysis revealed downregulation of complement receptor 1 in clonal B cells in cold agglutinin disease
    Clin Exp Immunol, 216 (1), 45-54
    DOI 10.1093/cei/uxad135, PubMed 38133636
21. McDonald GB, Landsverk OJB, McGovern DPB, Aasebø A, Paulsen V, Haritunians T, Reims HM, McLaughlin BM, Zisman T, Li D, Elholm ETMM, Jahnsen FL, Georges GE, Gedde-Dahl T (2024)
    Allogeneic bone marrow transplantation for patients with treatment-refractory Crohn's Disease
    Heliyon, 10 (1), e24026
    DOI 10.1016/j.heliyon.2024.e24026, PubMed 38283244
22. Montoro J, Eikema DJ, Tuffnell J, Potter V, Kałwak K, Halkes CJJ, Kulagin A, Collin M, Wynn RF, Robinson S, Nicholson E, Sengeloev H, Halahleh K, Skorobogatova E, Sanz J, Passweg JR, Mielke S, Ryhänen SJ, Carpenter B, Gedde-Dahl T, Tholouli E, Fanin R, Lewalle P, Kulasekararaj AG, Risitano AM et al. (2024)
    Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT
    Blood (in press)
    DOI 10.1182/blood.2024024173, PubMed 38643511
23. Moukalled N, Labopin M, Versluis J, Socié G, Blaise D, Salmenniemi U, Rambaldi A, Gedde-Dahl T, Tholouli E, Kröger N, Bourhis JH, Von Dem Borne P, Daguindau E, Forcade E, Nagler A, Esteve J, Ciceri F, Bazarbachi A, Mohty M (2024)
    Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
    Am J Hematol, 99 (3), 360-369
    DOI 10.1002/ajh.27187, PubMed 38165072
24. Nagler A, Labopin M, Swoboda R, Schroeder T, Hamladji RM, Griskevicius L, Salmenniemi U, Rambaldi A, Mielke S, Kulagin A, Passweg J, Luft T, Gedde-Dahl T, Forcade E, Helbig G, Stelljes M, Castilla-Llorente C, Spyridonidis A, Brissot E, Ciceri F, Mohty M (2024)
    Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Bone Marrow Transplant (in press)
    DOI 10.1038/s41409-024-02284-5, PubMed 38615143
25. Nielsen LK, Schjesvold F, Möller S, Guldbrandsen N, Hansson M, Remes K, Peceliunas V, Abildgaard N, Gregersen H, King MT (2024)
    Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group
    J Patient Rep Outcomes, 8 (1), 15
    DOI 10.1186/s41687-024-00691-2, PubMed 38315268
26. Nørgaard JN, Moore KLF, Slørdahl TS, Vik A, Tvedt THA, Schjesvold F (2024)
    VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study
    Blood Cancer J, 14 (1), 60
    DOI 10.1038/s41408-024-01047-1, PubMed 38594252
27. Panagopoulos I, Andersen K, Wik HS, Tandsæther MR (2024)
    Acute Lymphoblastic Leukemia With Near-haploid Karyotype and Philadelphia Chromosome
    Anticancer Res, 44 (4), 1389-1397
    DOI 10.21873/anticanres.16935, PubMed 38537997
28. Partanen A, Waage A, Peceliunas V, Schjesvold F, Anttila P, Säily M, Uttervall K, Putkonen M, Carlson K, Haukas E, Sankelo M, Szatkowski D, Hansson M, Marttila A, Svensson R, Axelsson P, Lauri B, Mikkola M, Karlsson C, Abelsson J, Ahlstrand E, Sikiö A, Klimkowska M, Matuzeviciene R, Fenstad MH et al. (2024)
    Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group
    Cancers (Basel), 16 (5)
    DOI 10.3390/cancers16051024, PubMed 38473382
29. Penack O, Abouqateb M, Peczynski C, Boreland W, Gülbas Z, Gedde-Dahl T, Castilla-Llorente C, Kröger N, Eder M, Rambaldi A, Bonifazi F, Blau IW, Stelljes M, Dreger P, Moiseev I, Schoemans H, Koenecke C, Peric Z (2024)
    PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
    Blood Cancer J, 14 (1), 45
    DOI 10.1038/s41408-024-01032-8, PubMed 38485723
30. Penack O, Abouqateb M, Peczynski C, Boreland W, Kröger N, Stelljes M, Gedde-Dahl T, Blau IW, Schroeder T, Salmenniemi U, Kulagin A, Peffault de Latour R, Mielke S, Zeiser R, Moiseev I, Schoemans H, Koenecke C, Peric Z (2024)
    ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
    Leukemia (in press)
    DOI 10.1038/s41375-024-02225-7, PubMed 38538862
31. Podgorica M, Drivet E, Viken JK, Richman A, Vestbøstad J, Szodoray P, Kvam AK, Wik HS, Tjønnfjord GE, Munthe LA, Frietze S, Schjerven H (2024)
    Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis
    Eur J Haematol, 112 (5), 731-742
    DOI 10.1111/ejh.14164, PubMed 38192186
32. Pour L, Szarejko M, Bila J, Schjesvold FH, Spicka I, Maisnar V, Jurczyszyn A, Grudeva-Popova Z, Hájek R, Usenko G, Thuresson M, Norin S, Jarefors S, Bakker NA, Richardson PG, Mateos MV (2024)
    Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study
    Haematologica, 109 (3), 895-905
    DOI 10.3324/haematol.2023.283509, PubMed 37646660
33. Reding MT, Simpson M, Ducore J, Holme PA, Maas Enriquez M, Mancuso ME (2024)
    Long-term efficacy and safety of damoctocog alfa pegol prophylaxis in patients with haemophilia A aged 12-<18 years at enrolment into PROTECT VIII
    Acta Haematol (in press)
    DOI 10.1159/000538702, PubMed 38599195
34. Richardson PG, Perrot A, Miguel JS, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang SY, Minarik J, Cavo M, Prince HM, Macé S, Zhang R, Dubin F, Morisse MC, Anderson KC (2024)
    Isatuximab-pomalidomide-dexamethasone versus pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis
    Haematologica (in press)
    DOI 10.3324/haematol.2023.284325, PubMed 38299578
35. Rogn Å, Jensen JL, Iversen PO, Singh PB (2024)
    Post-COVID-19 patients suffer from chemosensory, trigeminal, and salivary dysfunctions
    Sci Rep, 14 (1), 3455
    DOI 10.1038/s41598-024-53919-y, PubMed 38342941
36. Rogn Å, Jensen JL, Iversen PO, Singh PB (2024)
    Publisher Correction: Post-COVID-19 patients suffer from chemosensory, trigeminal, and salivary dysfunctions
    Sci Rep, 14 (1), 9213
    DOI 10.1038/s41598-024-59915-6, PubMed 38649502
37. Røed-Undlien H, Schultz NH, Lunnan A, Husebråten IM, Wollmann BM, Molden E, Bjørnstad JL (2024)
    Corrigendum to < IN-VITRO APIXABAN REMOVAL BY CYTOSORB® WHOLE BLOOD ADSORBER. AN EXPERIMENTAL STUDY.> <[Journal of Cardiothoracic and Vascular Anesthesia 36/6 (2024) 1636 - 1644]>
    J Cardiothorac Vasc Anesth (in press)
    DOI 10.1053/j.jvca.2024.03.039, PubMed 38580477
38. Rørvik SD, Torkildsen S, Bruserud Ø, Tvedt THA (2024)
    Acute myeloid leukemia with rare recurring translocations-an overview of the entities included in the international consensus classification
    Ann Hematol, 103 (4), 1103-1119
    DOI 10.1007/s00277-024-05680-5, PubMed 38443661
39. Schjesvold FH, Ludwig H, Delimpasi S, Robak P, Coriu D, Tomczak W, Pour L, Spicka I, Dimopoulos MA, Masszi T, Chernova NG, Sandberg A, Thuresson M, Norin S, Bakker NA, Mateos MV, Richardson PG, Sonneveld P (2024)
    Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study
    Haematologica (in press)
    DOI 10.3324/haematol.2023.284635, PubMed 38426292
40. Tinholt M, Tekpli X, Torland LA, Tahiri A, Geisler J, Kristensen V, Sandset PM, Iversen N (2024)
    The breast cancer coagulome in the tumor microenvironment and its role in prognosis and treatment response to chemotherapy
    J Thromb Haemost (in press)
    DOI 10.1016/j.jtha.2024.01.003, PubMed 38237862
41. Tobiasson M, Pandzic T, Illman J, Nilsson L, Weström S, Ejerblad E, Olesen G, Björklund A, Olsnes Kittang A, Werlenius O, Lorentz F, Rasmussen B, Cammenga J, Weber D, Lindholm C, Wiggh J, Dimitriou M, Moen AE, Yip Lundström L, von Bahr L, Baltzer-Sollander K, Jädersten M, Kytölä S, Walldin G, Ljungman P et al. (2024)
    Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation
    J Clin Oncol, 42 (12), 1378-1390
    DOI 10.1200/JCO.23.01159, PubMed 38232336
42. van der Maas NG, Versluis J, Nasserinejad K, van Rosmalen J, Pabst T, Maertens J, Breems D, Manz M, Cloos J, Ossenkoppele GJ, Floisand Y, Gradowska P, Löwenberg B, Huls G, Postmus D, Pignatti F, Cornelissen JJ (2024)
    Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial
    Blood Cancer J, 14 (1), 56
    DOI 10.1038/s41408-024-01037-3, PubMed 38538587
43. Vethe NT, Andersen AM, Gedde-Dahl T, Büchner J, Bergan S (2024)
    Therapeutic Drug Monitoring of Intravenous Busulfan and Analytical Challenges due to the Drug Formulation Excipient PEG 400: Letter to the Editor
    Ther Drug Monit (in press)
    DOI 10.1097/FTD.0000000000001209, PubMed 38648662
44. Wang HL, Siow R, Schmauck-Medina T, Zhang J, Sandset PM, Filshie C, Lund Ø, Partridge L, Bergersen LH, Juel Rasmussen L, Palikaras K, Sotiropoulos I, Storm-Mathisen J, Rubinsztein DC, Spillantini MG, De Zeeuw CI, Watne LO, Vyhnalek M, Veverova K, Liang KX, Tavernarakis N, Bohr VA, Yokote K, Saarela J, Nilsen H et al. (2024)
    Meeting Summary of The NYO3 5th NO-Age/AD Meeting and the 1st Norway-UK Joint Meeting on Aging and Dementia: Recent Progress on the Mechanisms and Interventional Strategies
    J Gerontol A Biol Sci Med Sci, 79 (4)
    DOI 10.1093/gerona/glae029, PubMed 38289789
45. Zaboras Z, Jørgensen CT, Stensvold A, Pettersen HH, Grdinic AG, Brækkan SK, Ghanima W, Tavoly M (2024)
    Real-world Data on Treatment Patterns and Bleeding in Cancer-associated Thrombosis: Data from the TROLL Registry
    TH Open, 8 (1), e132-e140
    DOI 10.1055/s-0044-1782219, PubMed 38532938

Publications 2023

1. Ahmed M, Muhoozi GKM, Atukunda P, Westerberg AC, Iversen PO, Wangen KR (2023)
   Cognitive development among children in a low-income setting: Cost-effectiveness analysis of a maternal nutrition education intervention in rural Uganda
   PLoS One, 18 (8), e0290379
   DOI 10.1371/journal.pone.0290379, PubMed 37594989
2. Al Hamed R, Ngoya M, Galimard JE, Sengeloev H, Gedde-Dahl T, Kulagin A, Platzbecker U, Yakoub-Agha I, Byrne JL, Valerius T, Socie G, Kröger N, Blaise D, Bazarbachi A, Sanz J, Ciceri F, Nagler A, Mohty M (2023)
   Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia-Improved outcomes over time: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party study
   Cancer, 129 (17), 2645-2654
   DOI 10.1002/cncr.34843, PubMed 37269074
3. Ali MM, Gedde-Dahl T, Osnes LT, Perrier F, Veierød MB, Tjønnfjord GE, Iversen PO (2023)
   Extracorporeal Photopheresis as Graft-versus-Host Disease Prophylaxis: A Randomized Controlled Trial
   Transplant Cell Ther, 29 (6), 364.e1-364.e11
   DOI 10.1016/j.jtct.2023.02.023, PubMed 36878428
4. Andersen AN, Brodersen AM, Ayuda-Durán P, Piechaczyk L, Tadele DS, Baken L, Fredriksen J, Stoksflod M, Lenartova A, Fløisand Y, Skånland SS, Enserink JM (2023)
   Clinical forecasting of acute myeloid leukemia using ex vivo drug-sensitivity profiling
   Cell Rep Methods, 3 (12), 100654
   DOI 10.1016/j.crmeth.2023.100654, PubMed 38065095
5. Arnold DM, Clerici B, Ilicheva E, Ghanima W (2023)
   Refractory immune thrombocytopenia in adults: Towards a new definition
   Br J Haematol, 203 (1), 23-27
   DOI 10.1111/bjh.19075, PubMed 37642211
6. Arvanitakis A, Holme PA, Berntorp E, Astermark J (2023)
   Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health-related quality of life in patients with severe haemophilia A
   Haemophilia, 29 (4), 1032-1038
   DOI 10.1111/hae.14806, PubMed 37252898
7. Astermark J, Baghaei F, Strandberg K, Toplican PG, Birkedal MF, Grahn EE, Hansson C, Kampmann P, Lehtinen AE, Täckström K, Holme PA, Magnusson M (2023)
   Infrastructural considerations of implementing gene therapy for hemophilia in the Nordic context
   Ther Adv Hematol, 14, 20406207231202306
   DOI 10.1177/20406207231202306, PubMed 37859645
8. Ayuda-Durán P, Hermansen JU, Giliberto M, Yin Y, Hanes R, Gordon S, Kuusanmäki H, Brodersen AM, Andersen AN, Taskén K, Wennerberg K, Enserink JM, Skånland SS (2023)
   Standardized assays to monitor drug sensitivity in hematologic cancers
   Cell Death Discov, 9 (1), 435
   DOI 10.1038/s41420-023-01722-5, PubMed 38040674
9. Bach-Gansmo T, Hodt A, Schjesvold FH, Gude E, Wien TN (2023)
   Bone scintigraphy reduces the need for biopsy in suspected cardiac amyloidosis
   Tidsskr Nor Laegeforen, 143 (9)
   DOI 10.4045/tidsskr.22.0644, PubMed 37341415
10. Bazarbachi A, Labopin M, Gedde-Dahl T, Remenyi P, Forcade E, Kröger N, Socié G, Craddock C, Bourhis JH, Versluis J, Yakoub-Agha I, Salmenniemi U, El-Cheikh J, Bug G, Esteve J, Nagler A, Ciceri F, Mohty M (2023)
    Improved Posttransplant Outcomes in Recent Years for AML Patients with FLT3-ITD and Wild-type NPM1: A Report from the EBMT Acute Leukemia Working Party
    Clin Cancer Res, 29 (21), 4441-4448
    DOI 10.1158/1078-0432.CCR-23-0954, PubMed 37603683
11. Cooper N, Ghanima W, Vianelli N, Valcárcel D, Yavaşoğlu İ, Melikyan A, Ruiz EY, Haenig J, Somenzi O, Lee J, Clark J, Zhang Y, Zaja F (2023)
    Sustained response off-treatment in eltrombopag-treated adult patients with ITP who are refractory or relapsed after first-line steroids: Primary, final, and ad-hoc analyses of the Phase II TAPER trial
    Am J Hematol, 99 (1), 57-67
    DOI 10.1002/ajh.27131, PubMed 38014779
12. Danielsen AS, Franconeri L, Page S, Myhre AE, Tornes RA, Kacelnik O, Bjørnholt JV (2023)
    Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models
    BMC Infect Dis, 23 (1), 247
    DOI 10.1186/s12879-023-08182-3, PubMed 37072711
13. Dusingizimana T, Ramilan T, Weber JL, Iversen PO, Mugabowindekwe M, Ahishakiye J, Brough L (2023)
    Predictors for achieving adequate antenatal care visits during pregnancy: a cross-sectional study in rural Northwest Rwanda
    BMC Pregnancy Childbirth, 23 (1), 69
    DOI 10.1186/s12884-023-05384-0, PubMed 36703102
14. Enden T (2023)
    In training or at work?
    Tidsskr Nor Laegeforen, 143 (2)
    DOI 10.4045/tidsskr.23.0031, PubMed 36718885
15. Enden T (2023)
    Equality under the Health Research Act
    Tidsskr Nor Laegeforen, 143 (9)
    DOI 10.4045/tidsskr.23.0386, PubMed 37341395
16. Enden T (2023)
    Peer reviewers, commonship and ownership
    Tidsskr Nor Laegeforen, 143 (17)
    DOI 10.4045/tidsskr.23.0751, PubMed 37987061
17. Enden T (2023)
    [Not Available]
    Tidsskr Nor Laegeforen, 143
    DOI 10.4045/tidsskr.23.0843, PubMed 38372223
18. Ettingshausen CE, Hermans C, Holme PA, Cid AR, Khair K, Oldenburg J, Négrier C, Botha J, Lelli A, Windyga J (2023)
    Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study
    Ther Adv Hematol, 14, 20406207231184323
    DOI 10.1177/20406207231184323, PubMed 37529276
19. Fagerhol MK, Schultz NH, Mirlashari MR, Wiedmann MKH, Nissen-Meyer LSH, Søraas AVL, Hetland G (2023)
    DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV-19 vaccination and in normal unvaccinated blood donors
    Scand J Immunol, 98 (1), e13274
    DOI 10.1111/sji.13274, PubMed 37676118
20. Federico L, Tvedt THA, Gainullin M, Osen JR, Chaban V, Lund KP, Tietze L, Tran TT, Lund-Johansen F, Kared H, Lind A, Vaage JT, Stratford R, Tennøe S, Malone B, Clancy T, Myhre AEL, Gedde-Dahl T, Munthe LA (2023)
    Robust spike-specific CD4⁺ and CD8⁺ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study
    Front Immunol, 14, 1210899
    DOI 10.3389/fimmu.2023.1210899, PubMed 37503339
21. Fløisand Y, Remberger M, Bigalke I, Josefsen D, Vålerhaugen H, Inderberg EM, Olaussen RW, Gjertsen BT, Goedkoop R, Geiger C, Prinz PU, Schnorfeil FM, Pinkernell K, Schendel DJ, Kvalheim G (2023)
    WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy
    Leukemia, 37 (9), 1842-1849
    DOI 10.1038/s41375-023-01980-3, PubMed 37507426
22. Geelen IGP, Gullaksen SE, Ilander MM, Olssen-Strömberg U, Mustjoki S, Richter J, Blijlevens NMA, Smit WM, Gjertsen BT, Gedde-Dahl T, Markevärn B, Koppes MMA, Westerweel PE, Hjorth-Hansen H, Janssen JJWM (2023)
    Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects
    Ann Hematol, 102 (6), 1395-1408
    DOI 10.1007/s00277-023-05199-1, PubMed 37119314
23. Giannakopoulou E, Lehander M, Virding Culleton S, Yang W, Li Y, Karpanen T, Yoshizato T, Rustad EH, Nielsen MM, Bollineni RC, Tran TT, Delic-Sarac M, Gjerdingen TJ, Douvlataniotis K, Laos M, Ali M, Hillen A, Mazzi S, Chin DWL, Mehta A, Holm JS, Bentzen AK, Bill M, Griffioen M, Gedde-Dahl T et al. (2023)
    A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo
    Nat Cancer, 4 (10), 1474-1490
    DOI 10.1038/s43018-023-00642-8, PubMed 37783807
24. Gjærde LK, Ruutu T, Peczynski C, Boreland W, Kröger N, Blaise D, Schroeder T, Peffault de Latour R, Gedde-Dahl T, Kulagin A, Sengeløv H, Yakoub-Agha I, Finke J, Eder M, Basak G, Moiseev I, Schoemans H, Koenecke C, Penack O, Perić Z (2023)
    The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working Party
    Bone Marrow Transplant, 59 (2), 255-263
    DOI 10.1038/s41409-023-02154-6, PubMed 38062242
25. Gleditsch J, Jervan Ø, Klok F, Holst R, Hopp E, Tavoly M, Ghanima W (2023)
    Does the clot burden as assessed by the Mean Bilateral Proximal Extension of the Clot score reflect mortality and adverse outcome after pulmonary embolism?
    Acta Radiol Open, 12 (6), 20584601231187094
    DOI 10.1177/20584601231187094, PubMed 37426515
26. Gotlib J, Castells M, Elberink HO, Siebenhaar F, Hartmann K, Broesby-Olsen S, George TI, Panse J, Alvarez-Twose I, Radia DH, Tashi T, Bulai Livideanu C, Sabato V, Heaney M, Van Daele P, Cerquozzi S, Dybedal I, Reiter A, Pongdee T, Barete S, Ustun C, Schwartz L, Ward BR, Schafhausen P, Vadas P et al. (2023)
    Avapritinib versus Placebo in Indolent Systemic Mastocytosis
    NEJM Evid, 2 (6), EVIDoa2200339
    DOI 10.1056/EVIDoa2200339, PubMed 38320129
27. Groen K, Schjesvold FH, van der Holt B, Levin MD, Seefat MR, Hansson M, Leys MBL, Regelink JC, Waage A, Szatkowski D, Axelsson P, Hieu Do T, Svirskaite A, van der Spek E, Haukas E, Knut-Bojanowska D, Ypma PF, Blimark CH, Mellqvist UH, van de Donk NWCJ, Sonneveld P, Klostergaard A, Vangsted AJ, Abildgaard N, Zweegman S (2023)
    Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13
    Hemasphere, 7 (9), e940
    DOI 10.1097/HS9.0000000000000940, PubMed 37663673
28. Gudmundstuen AM, Efficace F, Tjønnfjord GE, Skaarud KJ, Cottone F, Hjermstad MJ, Iversen PO (2023)
    The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial
    Ann Hematol, 102 (4), 927-935
    DOI 10.1007/s00277-023-05149-x, PubMed 36864210
29. Gundesen MT, Asmussen JT, Schjesvold F, Vangsted AJ, Helleberg C, Haukås E, Silkjær T, Teodorescu EM, Jensen BA, Slørdahl TS, Nahi H, Waage A, Abildgaard N, Lund T, Nordic Myeloma Study Group (2023)
    Potential value of pre-planned imaging of bone disease in multiple myeloma
    Blood Cancer J, 13 (1), 105
    DOI 10.1038/s41408-023-00880-0, PubMed 37419876
30. Harrison SP, Siller R, Tanaka Y, Chollet ME, de la Morena-Barrio ME, Xiang Y, Patterson B, Andersen E, Bravo-Pérez C, Kempf H, Åsrud KS, Lunov O, Dejneka A, Mowinckel MC, Stavik B, Sandset PM, Melum E, Baumgarten S, Bonanini F, Kurek D, Mathapati S, Almaas R, Sharma K, Wilson SR, Skottvoll FS et al. (2023)
    Scalable production of tissue-like vascularized liver organoids from human PSCs
    Exp Mol Med, 55 (9), 2005-2024
    DOI 10.1038/s12276-023-01074-1, PubMed 37653039
31. Hasanaliyeva G, Sufar EK, Wang J, Rempelos L, Volakakis N, Iversen PO, Leifert C (2023)
    Effects of Agricultural Intensification on Mediterranean Diets: A Narrative Review
    Foods, 12 (20)
    DOI 10.3390/foods12203779, PubMed 37893672
32. Hermans C, Astermark J, Carvalho M, Dolan G, d'Oiron R, Fontana P, Holme PA, Kenet G, Klamroth R, Mancuso ME, Marquardt N, Nunez R, Katsarou O, Pabinger-Fasching I, Quintavalle G, Rodgers R, van der Valk P, Windyga J, Jimenez Yuste V, Preložnik Zupan I (2023)
    Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe
    Haemophilia, 29 (3), 913-916
    DOI 10.1111/hae.14761, PubMed 36802089
33. Hermansen JU, Yin Y, Urban A, Myklebust CV, Karlsen L, Melvold K, Tveita AA, Taskén K, Munthe LA, Tjønnfjord GE, Skånland SS (2023)
    A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine
    Cell Death Discov, 9 (1), 125
    DOI 10.1038/s41420-023-01426-w, PubMed 37055391
34. Hernández-Boluda JC, Eikema DJ, Koster L, Kröger N, Robin M, de Witte M, Finke J, Finazzi MC, Broers A, Raida L, Schaap N, Chiusolo P, Verbeek M, Hazenberg CLE, Halaburda K, Kulagin A, Labussière-Wallet H, Gedde-Dahl T, Rabitsch W, Raj K, Drozd-Sokolowska J, Battipaglia G, Polverelli N, Czerw T, Yakoub-Agha I et al. (2023)
    Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
    Bone Marrow Transplant, 58 (12), 1357-1367
    DOI 10.1038/s41409-023-02094-1, PubMed 37679647
35. Hillarp A, Holme PA, Wåland EP, Le MS, Henriksson CE, Tjønnfjord GE, Måseide RJ (2023)
    Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII
    J Thromb Haemost, 21 (10), 2771-2775
    DOI 10.1016/j.jtha.2023.07.019, PubMed 37543216
36. Iversen PO, Fogelholm M (2023)
    Fluid and water balance: a scoping review for the Nordic Nutrition Recommendations 2023
    Food Nutr Res, 67
    DOI 10.29219/fnr.v67.9975, PubMed 38084150
37. Jervan Ø, Dhayyat A, Gleditsch J, Haukeland-Parker S, Tavoly M, Klok FA, Rashid D, Stavem K, Ghanima W, Steine K (2023)
    Demographic, clinical, and echocardiographic factors associated with residual perfusion defects beyond six months after pulmonary embolism
    Thromb Res, 229, 7-14
    DOI 10.1016/j.thromres.2023.06.004, PubMed 37356172
38. Jervan Ø, Haukeland-Parker S, Gleditsch J, Tavoly M, Klok FA, Steine K, Johannessen HH, Spruit MA, Atar D, Holst R, Astrup Dahm AE, Sirnes PA, Stavem K, Ghanima W (2023)
    The Effects of Exercise Training in Patients With Persistent Dyspnea Following Pulmonary Embolism: A Randomized Controlled Trial
    Chest, 164 (4), 981-991
    DOI 10.1016/j.chest.2023.04.042, PubMed 37149257
39. Jørgensen CT, Brækkan SK, Førsund E, Pettersen HH, Tjønnfjord E, Ghanima W, Tavoly M (2023)
    Incidence of venous thromboembolism, recurrence, and bleeding after isolated superficial vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital
    J Thromb Haemost, 22 (2), 526-533
    DOI 10.1016/j.jtha.2023.10.017, PubMed 37913911
40. Jørgensen CT, Tavoly M, Førsund E, Pettersen HH, Tjønnfjord E, Ghanima W, Brækkan SK (2023)
    Incidence of bleeding and recurrence in isolated distal deep vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital
    J Thromb Haemost, 21 (10), 2824-2832
    DOI 10.1016/j.jtha.2023.06.028, PubMed 37394122
41. Jørgensen OJ, Steineger JE, Hillarp A, Pareli Wåland E, Holme PA, Heimdal K, Dheyauldeen S (2023)
    Elevated FVIII levels in hereditary hemorrhagic telangiectasia: Implications for clinical management
    Laryngoscope Investig Otolaryngol, 9 (1), e1196
    DOI 10.1002/lio2.1196, PubMed 38362186
42. Kihlberg K, Baghaei F, Bruzelius M, Funding E, Andre Holme P, Lassila R, Nummi V, Ranta S, Gretenkort Andersson N, Berntorp E, Astermark J (2023)
    No difference in quality of life between persons with severe haemophilia A and B
    Haemophilia, 29 (4), 987-996
    DOI 10.1111/hae.14759, PubMed 36791275
43. Kisali EP, Iversen PO, Makani J, Sickle Cell Programme, MUHAS (2023)
    Low vitamin B₁₂ blood levels in sickle cell disease: Data from a large cohort study in Tanzania
    Br J Haematol, 204 (3), 1047-1053
    DOI 10.1111/bjh.19265, PubMed 38087805
44. Kreyberg I, Schrumpf E, Fredrik von Krogh C, Lilleng R, Tjønnfjord GE (2023)
    Successful treatment of subcorneal pustular dermatosis targeting an underlying monoclonal IgA gammopathy
    JAAD Case Rep, 41, 33-36
    DOI 10.1016/j.jdcr.2023.08.036, PubMed 37842157
45. Kristoffersen I, Holte K, Antonsen LP, Ho APT, Kvenshagen LN, Løgavlen VV, Murugaiah P, Tjønnfjord E, Værnesbranden MR (2023)
    A pregnant woman in her thirties with abdominal pain, seizures and haemorrhagic shock
    Tidsskr Nor Laegeforen, 143 (5)
    DOI 10.4045/tidsskr.22.0282, PubMed 36987892
46. Kverneland M, Nakken KO, Hofoss D, Skogan AH, Iversen PO, Selmer KK, Lossius MI (2023)
    Health-related quality of life in adults with drug-resistant focal epilepsy treated with modified Atkins diet in a randomized clinical trial
    Epilepsia, 64 (5), e69-e74
    DOI 10.1111/epi.17585, PubMed 36923995
47. Köhn-Luque A, Myklebust EM, Tadele DS, Giliberto M, Schmiester L, Noory J, Harivel E, Arsenteva P, Mumenthaler SM, Schjesvold F, Taskén K, Enserink JM, Leder K, Frigessi A, Foo J (2023)
    Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data
    Cell Rep Methods, 3 (3), 100417
    DOI 10.1016/j.crmeth.2023.100417, PubMed 37056380
48. Larsen TL, Svalastoga M, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Paulsen PQ, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2023)
    Arterial events in cancer patients treated with apixaban for venous thrombosis
    Thromb Res, 228, 128-133
    DOI 10.1016/j.thromres.2023.05.017, PubMed 37327527
49. Ludwig H, Terpos E, van de Donk N, Mateos MV, Moreau P, Dimopoulos MA, Delforge M, Rodriguez-Otero P, San-Miguel J, Yong K, Gay F, Einsele H, Mina R, Caers J, Driessen C, Musto P, Zweegman S, Engelhardt M, Cook G, Weisel K, Broijl A, Beksac M, Bila J, Schjesvold F, Cavo M et al. (2023)
    Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
    Lancet Oncol, 24 (6), e255-e269
    DOI 10.1016/S1470-2045(23)00159-6, PubMed 37269857
50. Matlary RED, Grydeland M, Glosli H, Rueegg CS, Holme PA (2023)
    Physical activity in Norwegian teenagers and young adults with haemophilia A compared to general population peers
    Haemophilia, 29 (2), 658-667
    DOI 10.1111/hae.14752, PubMed 36723510
51. Matlary RED, Grydeland M, Glosli H, Rueegg CS, Holme PA (2023)
    Factors associated with physical activity in young people with haemophilia A on prophylaxis
    Haemophilia, 29 (3), 900-909
    DOI 10.1111/hae.14776, PubMed 36913380
52. Meshkovska B, Gebremariam MK, Atukunda P, Iversen PO, Wandel M, Lien N (2023)
    Barriers and facilitators to implementation of nutrition-related actions in school settings in low- and middle-income countries (LMICs): a qualitative systematic review using the Consolidated Framework for Implementation Research (CFIR)
    Implement Sci Commun, 4 (1), 73
    DOI 10.1186/s43058-023-00454-y, PubMed 37370179
53. Molteberg E, Thorsby PM, Kverneland M, Iversen PO, Selmer KK, Hofoss D, Nakken KO, Taubøll E (2023)
    Stress biomarkers in adult patients with drug-resistant epilepsy on a modified Atkins diet: A prospective study
    Epilepsia Open, 8 (4), 1331-1339
    DOI 10.1002/epi4.12808, PubMed 37574592
54. Moore KLF, Turesson I, Genell A, Klausen TW, Knut-Bojanowska D, Redder L, Sverrisdottir I, Thorsen J, Vangsted AJ, Blimark CH (2023)
    Improved survival in myeloma patients-a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden
    Haematologica, 108 (6), 1640-1651
    DOI 10.3324/haematol.2021.280424, PubMed 36300775
55. Myklebust-Hansen HJ, Hasvik E, Solyga VM, Ghanima W (2023)
    The feasibility of self-performing measurements of peripheral oxygen saturation and respiratory exercises in home-isolated COVID-19 patients-a single-arm prospective trial
    Pilot Feasibility Stud, 9 (1), 195
    DOI 10.1186/s40814-023-01415-x, PubMed 38042811
56. Måseide RJ, Berntorp E, Astermark J, Olsson A, Bruzelius M, Frisk T, Nummi V, Lassila R, Tjønnfjord GE, Holme PA (2023)
    Health-related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study)
    Haemophilia, 30 (1), 98-105
    DOI 10.1111/hae.14899, PubMed 37983883
57. Nagler A, Labopin M, Kröger N, Schroeder T, Gedde-Dahl T, Eder M, Franke GN, Blau IW, Salmenniemi U, Socie G, Schetelig J, Stelljes M, Ciceri F, Mohty M (2023)
    The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT
    Bone Marrow Transplant, 58 (12), 1339-1347
    DOI 10.1038/s41409-023-02095-0, PubMed 37660157
58. Nagler A, Labopin M, Mielke S, Passweg J, Blaise D, Gedde-Dahl T, Cornelissen JJ, Salmenniemi U, Yakoub-Agha I, Reményi P, Socié G, van Gorkom G, Labussière-Wallet H, Huang XJ, Rubio MT, Byrne J, Craddock C, Griškevičius L, Ciceri F, Mohty M (2023)
    Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMT
    Bone Marrow Transplant, 58 (7), 791-800
    DOI 10.1038/s41409-023-01980-y, PubMed 37045942
59. Nahalomo A, Iversen PO, Andreassen BA, Kaaya A, Rukooko AB, Rukundo PM (2023)
    Food insecurity, dietary diversity and the right to adequate food among households in landslide-prone communities in Eastern Uganda: A cohort study
    PLoS One, 18 (4), e0283078
    DOI 10.1371/journal.pone.0283078, PubMed 37053147
60. Nezvalova-Henriksen K, Langebrake C, Bauters T, Moreno-Martinez ME, Ahnfelt E, Ekelund H, Domingos V, Pires V, Bonnin A, Bojanić I, Cabrerizo Y, Terwel S, Tam A (2023)
    Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group
    Bone Marrow Transplant, 58 (10), 1069-1074
    DOI 10.1038/s41409-023-02072-7, PubMed 37528237
61. Nyquist OE, Dalgaard J, Spetalen S, Torkildsen S, Frøen H, Galteland E, Klungsøyr O, Bergrem A, Vo C, Sørbø H, Eiken B, Lerdal H, Solvang AK, Jensvoll H, Pandzic T, Baliakas P, Dybedal I (2023)
    Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML
    Br J Haematol, 204 (2), 724-729
    DOI 10.1111/bjh.19226, PubMed 38016923
62. Nørgaard JN, Abildgaard N, Lysén A, Tsykunova G, Vangsted AJ, João C, Remen N, Nielsen LK, Osnes L, Stokke C, Connelly JP, Revheim MR, Nordic Myeloma Study Group (NMSG), Schjesvold F (2023)
    Intensifying treatment in PET-positive multiple myeloma patients after upfront autologous stem cell transplantation
    Leukemia, 37 (10), 2107-2114
    DOI 10.1038/s41375-023-01998-7, PubMed 37568010
63. Oriol A, Dimopoulos M, Schjesvold F, Beksac M, Facon T, Dhanasiri S, Guo S, Mu Y, Hong K, Gentili C, Galli M, Yagci M, Larocca A, Richardson P, Weisel K (2023)
    Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment
    Clin Lymphoma Myeloma Leuk, 24 (3), 165-176.e4
    DOI 10.1016/j.clml.2023.10.009, PubMed 38072743
64. Panagopoulos I, Andersen K, Wik HS, Tandsæther MR, Micci F, Heim S (2023)
    Acute Undifferentiated Leukemia With a Balanced t(5;10)(q35;p12) Resulting in Fusion of HNRNPH1 With MLLT10
    Cancer Genomics Proteomics, 20 (4), 354-362
    DOI 10.21873/cgp.20387, PubMed 37400142
65. Pedersen S, Kverneland M, Rudi K, Gervin K, Landmark CJ, Iversen PO, Selmer KK (2023)
    Decreased serum concentrations of antiseizure medications in children with drug resistant epilepsy following treatment with ketogenic diet
    Epilepsia Open, 8 (3), 858-866
    DOI 10.1002/epi4.12746, PubMed 37057954
66. Plesner T, Harrison SJ, Quach H, Lee C, Bryant A, Vangsted A, Estell J, Delforge M, Offner F, Twomey P, Choeurng V, Li J, Hendricks R, Ruppert SM, Sumiyoshi T, Miller K, Cho E, Schjesvold F (2023)
    Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma
    Clin Hematol Int, 5 (1), 43-51
    DOI 10.1007/s44228-022-00023-5, PubMed 36656461
67. Poiré X, Labopin M, Polge E, Ganser A, Socié G, Gedde-Dahl T, Forcade E, Finke J, Chalandon Y, Bulabois CE, Yakoub-Agha I, Aljurf M, Kröger N, Blau IW, Nagler A, Esteve J, Mohty M (2023)
    Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotype
    Bone Marrow Transplant, 59 (2), 264-269
    DOI 10.1038/s41409-023-02167-1, PubMed 38092959
68. Pradier M, Rodger MA, Ghanima W, Kovacs MJ, Shivakumar S, Kahn SR, Sandset PM, Kearon C, Mallick R, Delluc A (2023)
    Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation Study
    Thromb Haemost, 123 (7), 692-699
    DOI 10.1055/a-2039-3388, PubMed 36809776
69. Reding MT, Pabinger I, Holme PA, Maas Enriquez M, Mancuso ME, Lalezari S, Miesbach W, Di Minno G, Klamroth R, Hermans C (2023)
    Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hoc analysis from the PROTECT VIII study
    Ther Adv Hematol, 14, 20406207231166779
    DOI 10.1177/20406207231166779, PubMed 37113811
70. Rempelos L, Wang J, Sufar EK, Almuayrifi MSB, Knutt D, Leifert H, Leifert A, Wilkinson A, Shotton P, Hasanaliyeva G, Bilsborrow P, Wilcockson S, Volakakis N, Markellou E, Zhao B, Jones S, Iversen PO, Leifert C (2023)
    Breeding Bread-Making Wheat Varieties for Organic Farming Systems: The Need to Target Productivity, Robustness, Resource Use Efficiency and Grain Quality Traits
    Foods, 12 (6)
    DOI 10.3390/foods12061209, PubMed 36981136
71. Rinde FB, Jørgensen CT, Pettersen HH, Hansen JB, Ghanima W, Braekkan SK (2023)
    Low D-dimer levels at diagnosis of venous thromboembolism are associated with reduced risk of recurrence: data from the TROLL registry
    J Thromb Haemost, 21 (7), 1861-1868
    DOI 10.1016/j.jtha.2023.03.026, PubMed 37004791
72. Robin C, Cordonnier C, Tridello G, Knelange N, Xhaard A, Chantepie S, Tanguy-Schmidt A, Schouten HC, Yeshurun M, Rocha V, Srour M, Kröger N, Ledoux MP, Dalgaard J, Thiebaut A, Giardino S, Calore E, Zuckerman T, Groll AH, Raida L, Avcin S, Vicent MG, Kaare A, Drozd-Sokolowska J, Turlure P et al. (2023)
    Pneumocystis Pneumonia After Allogeneic Hematopoietic Cell Transplantation: A Case-Control Study on Epidemiology and Risk Factors on Behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
    Transplant Cell Ther, 30 (2), 235.e1-235.e10
    DOI 10.1016/j.jtct.2023.11.017, PubMed 38007092
73. Roman G, Stavik B, Lauritzen KH, Sandset PM, Harrison SP, Sullivan GJ, Chollet ME (2023)
    "iPSC-derived liver organoids and inherited bleeding disorders: Potential and future perspectives"
    Front Physiol, 14, 1094249
    DOI 10.3389/fphys.2023.1094249, PubMed 36711019
74. Ruggeri A, De Wreede LC, Müller CR, Crivello P, Bonneville EF, Petersdorf EW, Socié G, Dubois V, Niittyvuopio R, Peräsaari J, Yakoub-Agha I, Cornelissen JJ, Wieten L, Gedde-Dahl T, Forcade E, Crawley CR, Marsh SGE, Gandemer V, Tholouli E, Bulabois CE, Huynh A, Choi G, Deconinck E, Itäla-Remes M, Lenhoff S et al. (2023)
    Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation
    Haematologica, 108 (2), 645-652
    DOI 10.3324/haematol.2021.280055, PubMed 35546480
75. Rørvik SD, Abrahamsen IW, Myhre AE, Vo CD, Ødegaard EM, Bruserud Ø, Gedde-Dahl T, Tvedt THA (2023)
    [Chronic graft-versus-host disease]
    Tidsskr Nor Laegeforen, 143 (4)
    DOI 10.4045/tidsskr.22.0525, PubMed 36919292
76. Raab MS, Cohen YC, Schjesvold F, Aardalen K, Oka A, Spencer A, Wermke M, Souza AD, Kaufman JL, Cafro AM, Ocio EM, Doki N, Henson K, Trabucco G, Carrion A, Bender FC, Juif PE, Fessehatsion A, Fan L, Stonehouse JP, Blankenship JW, Granda B, De Vita S, Lu H (2023)
    Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody
    Leukemia, 37 (6), 1349-1360
    DOI 10.1038/s41375-023-01883-3, PubMed 37024520
77. Raab MS, Zamagni E, Manier S, Rodriguez-Otero P, Schjesvold F, Broijl A (2023)
    Difficult-to-treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results
    EJHaem, 4 (4), 1117-1131
    DOI 10.1002/jha2.743, PubMed 38024633
78. Sanz J, Labopin M, Pabst T, Versluis J, Van Gorkom G, Meijer E, Gedde-Dahl T, Montoro J, Arcese W, Pérez-Simón JA, Schaap N, Maertens J, Vrhovac R, Lanza F, Gorin NC, Mohty M, Ciceri F (2023)
    Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
    Bone Marrow Transplant, 58 (11), 1197-1202
    DOI 10.1038/s41409-023-02075-4, PubMed 37553468
79. Schjesvold FH, Ludwig H, Mateos MV, Larocca A, Abdulhaq H, Norin S, Thuresson M, Bakker NA, Richardson PG, Sonneveld P (2023)
    Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators: A subgroup analysis from the OCEAN study
    Eur J Haematol, 112 (3), 402-411
    DOI 10.1111/ejh.14127, PubMed 37968873
80. Schultz NH, Bechensteen AG, Tjønnfjord EB, Akkök ÇA, Berg MH (2023)
    New interest group for red blood cell disorders
    Tidsskr Nor Laegeforen, 143 (3)
    DOI 10.4045/tidsskr.22.0731, PubMed 36811425
81. Shapiro AD, Nakar C, Parker JM, Thibaudeau K, Crea R, Sandset PM (2023)
    Plasminogen, human-tvmh for the treatment of children and adults with plasminogen deficiency type 1
    Haemophilia, 29 (6), 1556-1564
    DOI 10.1111/hae.14849, PubMed 37674358
82. Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, Perrot A, Cavo M, Belotti A, Broijl A, Gay F, Mina R, Nijhof IS, van de Donk NWCJ, Katodritou E, Schjesvold F, Sureda Balari A, Rosiñol L, Delforge M, Roeloffzen W, Silzle T et al. (2023)
    Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
    N Engl J Med, 390 (4), 301-313
    DOI 10.1056/NEJMoa2312054, PubMed 38084760
83. Sonneveld P, Richardson PG, Ludwig H, Dimopoulos MA, Schjesvold FH, Hájek R, Abdulhaq H, Thuresson M, Norin S, Bakker NA, Mateos MV (2023)
    Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies
    Clin Lymphoma Myeloma Leuk, 23 (9), 687-696
    DOI 10.1016/j.clml.2023.05.004, PubMed 37355418
84. Spyridonidis A, Labopin M, Gedde-Dahl T, Ganser A, Stelljes M, Craddock C, Wagner-Drouet EM, Versluis J, Schroeder T, Blau IW, Wulf GG, Dreger P, Olesen G, Sengeloev H, Kröger N, Potter V, Forcade E, Passweg J, de Latour RP, Maertens J, Wilson KMO, Bourhis JH, Finke J, Brissot E, Bazarbachi A et al. (2023)
    Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
    Bone Marrow Transplant, 59 (2), 217-223
    DOI 10.1038/s41409-023-02139-5, PubMed 37978322
85. Terpos E, Musto P, Engelhardt M, Delforge M, Cook G, Gay F, van de Donk NWCJ, Ntanasis-Stathopoulos I, Vangsted AJ, Driessen C, Schjesvold F, Cerchione C, Zweegman S, Hajek R, Moreau P, Einsele H, San-Miguel J, Boccadoro M, Dimopoulos MA, Sonneveld P, Ludwig H (2023)
    Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)
    Leukemia, 37 (6), 1175-1185
    DOI 10.1038/s41375-023-01920-1, PubMed 37142661
86. Tholin B, Ghanima W, Selle ML, Stavem K (2023)
    Incidence and determinants of venous thromboembolism over 90 days in hospitalized and nonhospitalized patients with COVID-19
    J Intern Med, 294 (6), 721-729
    DOI 10.1111/joim.13706, PubMed 37518983
87. Tislevoll BS, Hellesøy M, Fagerholt OHE, Gullaksen SE, Srivastava A, Birkeland E, Kleftogiannis D, Ayuda-Durán P, Piechaczyk L, Tadele DS, Skavland J, Baliakas P, Hovland R, Andresen V, Seternes OM, Tvedt THA, Aghaeepour N, Gavasso S, Porkka K, Jonassen I, Fløisand Y, Enserink J, Blaser N, Gjertsen BT (2023)
    Early response evaluation by single cell signaling profiling in acute myeloid leukemia
    Nat Commun, 14 (1), 115
    DOI 10.1038/s41467-022-35624-4, PubMed 36611026
88. Tislevoll BS, Hellesøy M, Fagerholt OHE, Gullaksen SE, Srivastava A, Birkeland E, Kleftogiannis D, Ayuda-Durán P, Piechaczyk L, Tadele DS, Skavland J, Baliakas P, Hovland R, Andresen V, Seternes OM, Tvedt THA, Aghaeepour N, Gavasso S, Porkka K, Jonassen I, Fløisand Y, Enserink J, Blaser N, Gjertsen BT (2023)
    Author Correction: Early response evaluation by single cell signaling profiling in acute myeloid leukemia
    Nat Commun, 14 (1), 1767
    DOI 10.1038/s41467-023-37488-8, PubMed 36997540
89. Tjønnfjord SKV, Ali MM, Tjønnfjord GE (2023)
    Chronic neutropenia in adults
    Tidsskr Nor Laegeforen, 143 (9)
    DOI 10.4045/tidsskr.22.0491, PubMed 37341406
90. Troensegaard H, Khoury J, Westerberg AC, Tonstad S, Roeters van Lennep J, Veierød MB, Iversen PO, Holven KB, Retterstøl K (2023)
    Protocol for a 20-year follow-up after a randomized controlled trial of a Mediterranean diet in pregnancy: maternal and offspring risk factors for cardiovascular disease
    Front Pediatr, 11, 1256815
    DOI 10.3389/fped.2023.1256815, PubMed 37920793
91. Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M et al. (2023)
    Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
    Crit Care, 27 (1), 9
    DOI 10.1186/s13054-022-04205-8, PubMed 36627655
92. Tsykunova G, Kristensen E, Stray-Pedersen A, Bruserud Ø, Sørensen IW, Bruserud Ø, Tvedt THA (2023)
    Adult presentation of ornithine transcarbamylase deficiency: a possible cause of hyperammonemia after high-dose chemotherapy and stem cell transplantation
    Hematology, 28 (1), 2265187
    DOI 10.1080/16078454.2023.2265187, PubMed 38078487
93. Ueland T, Michelsen AE, Tveita AA, Kåsine T, Dahl TB, Finbråten AK, Holten AR, Skjønsberg OH, Mathiessen A, Henriksen KN, Trøseid M, Aaløkken TM, Halvorsen B, Dyrhol-Riise AM, Barratt-Due A, Aukrust P (2023)
    Coagulopathy and adverse outcomes in hospitalized patients with COVID-19: results from the NOR-Solidarity trial
    Res Pract Thromb Haemost, 8 (1), 102289
    DOI 10.1016/j.rpth.2023.102289, PubMed 38292350
94. van de Donk NWCJ, Minnema MC, van der Holt B, Schjesvold F, Wu KL, Broijl A, Roeloffzen WWH, Gadisseur A, Pietrantuono G, Pour L, van der Velden VHJ, Lund T, Offidani M, Grasso M, Giaccone L, Razawy W, Tacchetti P, Mancuso K, Silkjaer T, Caers J, Zweegman S, Hájek R, Benjamin R, Vangsted AJ, Boccadoro M et al. (2023)
    Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study
    Lancet Oncol, 24 (10), 1119-1133
    DOI 10.1016/S1470-2045(23)00405-9, PubMed 37717583
95. Vinnes EW, Lillemoen PKS, Klingenberg O, Fjeld B, Iversen PO, Brodwall KM, Bechensteen AG (2023)
    [Sickle cell disease – clinical manifestations and diagnostics]
    Tidsskr Nor Laegeforen, 143 (3)
    DOI 10.4045/tidsskr.22.0353, PubMed 36811424
96. Vo CD, Myhre AE, Abrahamsen IW, Remberger M, Mattsson J, Fløisand Y, Grønvold BCL, Tjønnfjord GE, Tvedt THA, Gedde-Dahl T (2023)
    Allogeneic stem cell transplantation in adults 2015-21
    Tidsskr Nor Laegeforen, 143 (4)
    DOI 10.4045/tidsskr.22.0521, PubMed 36919291
97. Warlo EMK, Kalstad AA, Myhre PL, Solheim S, Arnesen H, Tveit A, Holme PA, Seljeflot I, Bratseth V (2023)
    von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction
    Res Pract Thromb Haemost, 7 (4), 100164
    DOI 10.1016/j.rpth.2023.100164, PubMed 37255854
98. Westhrin M, Blazevski J, Textor A, Abdollahi P, Gopalakrishnan RP, Ngo LT, Hofgaard PO, Heinzelbecker J, Bobic S, Fossum E, Spång HCL, Braathen R, Bogen B (2023)
    Id-neoantigen vaccine induces therapeutic CD8⁺ T cells against multiple myeloma: H chain-loss escapees cause FLC MM
    J Immunother Cancer, 11 (8)
    DOI 10.1136/jitc-2023-006944, PubMed 37607769
99. Ågnes C, Schwartz T, Quist-Paulsen E, Bhatti R, Njaastad AM, Fuglestved J, Wibetoe G (2023)
    Drug-induced aseptic meningitis
    Tidsskr Nor Laegeforen, 143 (1)
    DOI 10.4045/tidsskr.22.0286, PubMed 36655954

Publications 2022

1. Albert MH, Sirait T, Eikema DJ, Bakunina K, Wehr C, Suarez F, Fox ML, Mahlaoui N, Gennery AR, Lankester AC, Beier R, Bernardo ME, Bigley V, Lindemans CA, Burns SO, Carpenter B, Dybko J, Güngör T, Hauck F, Lum SH, Balashov D, Meisel R, Moshous D, Schulz A, Speckmann C et al. (2022)
   Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study
   Blood, 140 (14), 1635-1649
   DOI 10.1182/blood.2022015506, PubMed 35344580
2. Arvanitakis A, Holme PA, Berntorp E, Astermark J (2022)
   Clinical outcome and adherence rate in Scandinavian patients with intermediate-intensity prophylaxis before and after the switch of standard half-life FVIII products to BAY 81-8973
   Haemophilia, 28 (2), 223-229
   DOI 10.1111/hae.14489, PubMed 35005818
3. Berentsen S, Tjønnfjord GE (2022)
   Current Treatment Options in Cold Agglutinin Disease: B-Cell Directed or Complement Directed Therapy?
   Transfus Med Rev, 36 (4), 181-187
   DOI 10.1016/j.tmrv.2022.05.001, PubMed 36127205
4. Berge-Seidl S, Nielsen NV, Rodriguez Alfonso AA, Etscheid M, Kandanur SPS, Haug BE, Stensland M, Thiede B, Karacan M, Preising N, Wiese S, Ständker L, Declerck PJ, Løset GÅ, Kanse SM (2022)
   Identification of a Phage Display-Derived Peptide Interacting with the N-Terminal Region of Factor VII Activating Protease (FSAP) Enables Characterization of Zymogen Activation
   ACS Chem Biol, 17 (9), 2631-2642
   DOI 10.1021/acschembio.2c00538, PubMed 36070465
5. Bistervels IM, Bavalia R, Beyer-Westendorf J, Ten Cate-Hoek AJ, Schellong SM, Kovacs MJ, Falvo N, Meijer K, Stephan D, Boersma WG, Ten Wolde M, Couturaud F, Verhamme P, Brisot D, Kahn SR, Ghanima W, Montaclair K, Hugman A, Carroll P, Pernod G, Sanchez O, Ferrari E, Roy PM, Sevestre-Pietri MA, Birocchi S et al. (2022)
   Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin
   Res Pract Thromb Haemost, 6 (5), e12748
   DOI 10.1002/rth2.12748, PubMed 35992565
6. Bistervels IM, Buchmüller A, Wiegers HMG, Ní Áinle F, Tardy B, Donnelly J, Verhamme P, Jacobsen AF, Hansen AT, Rodger MA, DeSancho MT, Shmakov RG, van Es N, Prins MH, Chauleur C, Middeldorp S, Highlow Block writing committee, Highlow Investigators (2022)
   Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial
   Lancet, 400 (10365), 1777-1787
   DOI 10.1016/S0140-6736(22)02128-6, PubMed 36354038
7. Cui XY, Stavik B, Thiede B, Sandset PM, Kanse SM (2022)
   FSAP Protects against Histone-Mediated Increase in Endothelial Permeability In Vitro
   Int J Mol Sci, 23 (22)
   DOI 10.3390/ijms232213706, PubMed 36430180
8. de la Morena-Barrio ME, Suchon P, Jacobsen EM, Iversen N, Miñano A, de la Morena-Barrio B, Bravo-Pérez C, Padilla J, Cifuentes R, Asenjo S, Deleuze JF, Trégouët DA, Lozano ML, Vicente V, Sandset PM, Morange PE, Corral J (2022)
   Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays
   Blood, 140 (2), 140-151
   DOI 10.1182/blood.2021014708, PubMed 35486842
9. Delluc A, Ghanima W, Kovacs MJ, Shivakumar S, Kahn SR, Sandset PM, Kearon C, Mallick R, Rodger MA (2022)
   Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER)
   Thromb Res, 213, 119-124
   DOI 10.1016/j.thromres.2022.03.014, PubMed 35344784
10. Diep PP, Rueegg CS, Burman MM, Brinch L, Bø K, Fosså K, Landrø L, Loge JH, Lund MB, Massey RJ, Myrdal OH, Pathak M, Rimstad L, Tanem KE, Tjønnfjord GE, Aaløkken TM, Ruud E (2022)
    Graft-Versus-Host-Disease and Health-Related Quality of Life in Young Long-term Survivors of Cancer and Allogeneic Hematopoietic Stem Cell Transplantation
    J Adolesc Young Adult Oncol, 12 (1), 66-75
    DOI 10.1089/jayao.2021.0196, PubMed 35544321
11. Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, Delforge M, Hájek R, Schjesvold F, Cavo M, Goldschmidt H, Facon T, Einsele H, Boccadoro M, San-Miguel J, Sonneveld P, Mey U, EHA Guidelines Committee ESMO Guidelines Committee. Electronic address: guidelines@ehaweb.org (2022)
    Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]
    Ann Oncol, 33 (9), 988
    DOI 10.1016/j.annonc.2022.05.004, PubMed 35810138
12. Dimopoulos MA, Schjesvold F, Doronin V, Vinogradova O, Quach H, Leleu X, Montes YG, Ramasamy K, Pompa A, Levin MD, Lee C, Mellqvist UH, Fenk R, Demarquette H, Sati H, Vorog A, Labotka R, Du J, Darif M, Kumar S (2022)
    Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial
    Blood Cancer J, 12 (1), 9
    DOI 10.1038/s41408-021-00593-2, PubMed 35075109
13. Enden T (2022)
    [Not Available]
    Tidsskr Nor Laegeforen, 142
    DOI 10.4045/tidsskr.22.0656, PubMed 36303471
14. Engh MS, Muhoozi GKM, Ngari M, Skaare AB, Westerberg AC, Iversen PO, Brusevold IJ, Atukunda P (2022)
    Long-Term Effects of a Randomized Maternal Education Trial in Rural Uganda: Implications for Child Oral Health
    Am J Trop Med Hyg, 107 (4), 939-947
    DOI 10.4269/ajtmh.22-0248, PubMed 36067985
15. Etscheid M, Hanschmann KM, Sandset PM, Kanse SM (2022)
    Development of a Factor VII Activating Protease (FSAP) generation assay and its application in studying FSAP in venous thrombosis
    Thromb Res, 220, 24-34
    DOI 10.1016/j.thromres.2022.09.027, PubMed 36265411
16. Garabet L, Eriksson A, Tjønnfjord E, Cui XY, Olsen MK, Jacobsen HK, Jørgensen CT, Mathisen ÅB, Mowinckel MC, Ahlen MT, Sørvoll IH, Horvei KD, Ernstsen SL, Lægreid IJ, Stavik B, Holst R, Sandset PM, Ghanima W (2022)
    SARS-CoV-2 vaccines are not associated with hypercoagulability in apparently healthy people
    Res Pract Thromb Haemost, 7 (1), 100002
    DOI 10.1016/j.rpth.2022.100002, PubMed 36448024
17. Garcia-Horton A, Cyriac SL, Gedde-Dahl T, Floisand Y, Remberger M, Mattsson J, Michelis FV (2022)
    Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups
    Eur J Haematol, 109 (6), 672-679
    DOI 10.1111/ejh.13850, PubMed 36028979
18. Giliberto M, Thimiri Govinda Raj DB, Cremaschi A, Skånland SS, Gade A, Tjønnfjord GE, Schjesvold F, Munthe LA, Taskén K (2022)
    Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically
    Mol Oncol, 16 (6), 1241-1258
    DOI 10.1002/1878-0261.13191, PubMed 35148457
19. Gleditsch J, Jervan Ø, Haukeland-Parker S, Tavoly M, Geier O, Holst R, Klok FA, Johannessen HH, Ghanima W, Hopp E (2022)
    Effects of pulmonary rehabilitation on cardiac magnetic resonance parameters in patients with persistent dyspnea following pulmonary embolism
    Int J Cardiol Heart Vasc, 40, 100995
    DOI 10.1016/j.ijcha.2022.100995, PubMed 35345773
20. Gregersen I, Ueland T, Holter JC, Olsen MB, Michelsen AE, Murphy SL, Tveita AA, Henriksen KN, Hoel H, Nordberg LB, Holten AR, Edvardsen T, Yang K, Heggelund L, Trøseid M, Müller F, Kildal AB, Dyrhol-Riise AM, Barratt-Due A, Dahl TB, Aukrust P, Halvorsen B, NOR-SOLIDARITY consortium, The Norwegian SARS-CoV-2 Study Group investigators (2022)
    CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19
    J Infect, 85 (6), 702-769
    DOI 10.1016/j.jinf.2022.09.029, PubMed 36216188
21. Grob T, Sanders MA, Vonk CM, Kavelaars FG, Rijken M, Hanekamp DW, Gradowska PL, Cloos J, Fløisand Y, van Marwijk Kooy M, Manz MG, Ossenkoppele GJ, Tick LW, Havelange V, Löwenberg B, Jongen-Lavrencic M, Valk PJM (2022)
    Prognostic Value of FLT3-Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia
    J Clin Oncol, 41 (4), 756-765
    DOI 10.1200/JCO.22.00715, PubMed 36315929
22. Gundesen MT, Asmussen JT, Haukås E, Schubert M, Abildgaard N, Schjesvold F, Lund T (2022)
    A prospective study of Skeletal survey versus Low-dose whole-body CT for Osteolytic lesions in Multiple Myeloma
    Eur J Haematol, 108 (5), 423-429
    DOI 10.1111/ejh.13749, PubMed 35113466
23. Haroun-Izquierdo A, Vincenti M, Netskar H, van Ooijen H, Zhang B, Bendzick L, Kanaya M, Momayyezi P, Li S, Wiiger MT, Hoel HJ, Krokeide SZ, Kremer V, Tjonnfjord G, Berggren S, Wikström K, Blomberg P, Alici E, Felices M, Önfelt B, Höglund P, Valamehr B, Ljunggren HG, Björklund A, Hammer Q et al. (2022)
    Adaptive single-KIR⁺NKG2C⁺ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia
    J Immunother Cancer, 10 (11)
    DOI 10.1136/jitc-2022-005577, PubMed 36319065
24. Helland Å, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, Bjørge L, Blix E, Bjerkehagen B, Brabrand S, Cameron MG, Dalhaug A, Dietzel D, Dønnem T, Enerly E, Flobak Å, Fluge S, Gilje B, Gjertsen BT, Grønberg BH, Grønås K, Guren T, Hamre H, Haug Å, Heinrich D et al. (2022)
    Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
    J Transl Med, 20 (1), 225
    DOI 10.1186/s12967-022-03432-5, PubMed 35568909
25. Helland Å, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, Bjørge L, Blix E, Bjerkehagen B, Brabrand S, Cameron MG, Dalhaug A, Dietzel D, Dønnem T, Enerly E, Flobak Å, Fluge S, Gilje B, Gjertsen BT, Grønberg BH, Grønås K, Guren T, Hamre H, Haug Å, Heinrich D et al. (2022)
    Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
    J Transl Med, 20 (1), 317
    DOI 10.1186/s12967-022-03518-0, PubMed 35841045
26. Hetland G, Fagerhol MK, Wiedmann MKH, Søraas AVL, Mirlashari MR, Nissen-Meyer LSH, Istre MS, Holme PA, Schultz NH (2022)
    Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects
    Vaccines (Basel), 10 (8)
    DOI 10.3390/vaccines10081267, PubMed 36016155
27. Hjertholm KG, Holmboe-Ottesen G, Mdala I, Shi Z, Iversen PO (2022)
    The impact of dietary diversity and seasonality in food availability on the quantile distribution of birth size among pregnant women in rural Malawi - a cross-sectional study
    BMC Pregnancy Childbirth, 22 (1), 602
    DOI 10.1186/s12884-022-04924-4, PubMed 35897009
28. Horn MA, Myhre AE, Prescott T, Aasly J, Sundal CH, Gedde-Dahl T (2022)
    Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R-Related Leukoencephalopathy
    Mov Disord, 37 (5), 1108-1109
    DOI 10.1002/mds.29011, PubMed 35587623
29. Huuhtanen J, Ilander M, Yadav B, Dufva OM, Lähteenmäki H, Kasanen T, Klievink J, Olsson-Strömberg U, Stentoft J, Richter J, Koskenvesa P, Höglund M, Söderlund S, Dreimane A, Porkka K, Gedde-Dahl T, Gjertsen BT, Stenke L, Myhr-Eriksson K, Markevärn B, Lübking A, Dimitrijevic A, Udby L, Bjerrum OW, Hjorth-Hansen H et al. (2022)
    IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia
    J Clin Invest, 132 (17)
    DOI 10.1172/JCI152585, PubMed 36047494
30. Imbery JF, Heinzelbecker J, Jebsen JK, McGowan M, Myklebust C, Bottini N, Stanford SM, Skånland SS, Tveita A, Tjønnfjord GE, Munthe LA, Szodoray P, Nakken B (2022)
    T-helper cell regulation of CD45 phosphatase activity by galectin-1 and CD43 governs chronic lymphocytic leukaemia proliferation
    Br J Haematol, 198 (3), 556-573
    DOI 10.1111/bjh.18285, PubMed 35655388
31. Iversen PO, Hankin A, Horn J, Pedersen TH, Borgersen R, Frøen HM (2022)
    Deep Compartment Syndrome Without Myonecrosis: A Case Report on a Rare Complication of Sickle Cell Disease
    Cureus, 14 (9), e29164
    DOI 10.7759/cureus.29164, PubMed 36258983
32. Janssens R, Lang T, Vallejo A, Galinsky J, Morgan K, Plate A, De Ronne C, Verschueren M, Schoefs E, Vanhellemont A, Delforge M, Schjesvold F, Cabezudo E, Vandebroek M, Stevens H, Simoens S, Huys I (2022)
    What matters most to patients with multiple myeloma? A Pan-European patient preference study
    Front Oncol, 12, 1027353
    DOI 10.3389/fonc.2022.1027353, PubMed 36523996
33. Jønsson V, Awan H, Jones ND, Johannesen TB, Thøgersen K, Steig BÁ, Andorsdottir G, Tjønnfjord GE (2022)
    Meiotic drive in chronic lymphocytic leukemia compared with other malignant blood disorders
    Sci Rep, 12 (1), 6138
    DOI 10.1038/s41598-022-09602-1, PubMed 35413962
34. Jørgensen CT, Tavoly M, Pettersen HH, Førsund E, Roaldsnes C, Olsen MK, Tjønnfjord E, Gleditsch J, Galovic AG, Vikum SF, Brækkan SK, Ghanima W (2022)
    The venous thrombosis registry in Østfold Hospital (TROLL registry) - design and cohort description
    Res Pract Thromb Haemost, 6 (5)
    DOI 10.1002/rth2.12770, PubMed 35949883
35. Katenga-Kaunda LZ, Iversen PO, Kamudoni PR, Holmboe-Ottesen G, Fjeld HE (2022)
    Food-based nutrition counselling and education intervention for improved diets of pregnant women in rural Malawi: a qualitative study of factors influencing dietary behaviour change
    Public Health Nutr, 25 (9), 2436-2447
    DOI 10.1017/S1368980022000593, PubMed 35369896
36. Kihlberg K, Baghaei F, Bruzelius M, Funding E, Holme PA, Lassila R, Martin M, Nummi V, Ranta S, Strandberg K, Andersson NG, Berntorp E, Astermark J (2022)
    Factor IX antibodies and tolerance in hemophilia B in the Nordic countries - The impact of F9 variants and complications
    Thromb Res, 217, 22-32
    DOI 10.1016/j.thromres.2022.06.015, PubMed 35842956
37. Klamroth R, Ay C, De Moerloose P, Fontana P, Windyga J, Astermark J, Berntorp E, Carvalho M, Dolan G, Hermans C, Holme PA, Kenet G, Mancuso ME, Marquardt N, Nunez R, Pabinger I, Rodgers R, Valk PV, Yuste VJ, Zupan IP (2022)
    Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A - A modified Delphi consensus by the ADVANCE Working Group
    Haemophilia, 29 (1), 21-32
    DOI 10.1111/hae.14674, PubMed 36271497
38. Klintman J, Akesson KE, Holme PA, Fischer K (2022)
    Bone mineral density in haemophilia - a multicentre study evaluating the impact of different replacement regimens
    Haemophilia, 28 (2), 239-246
    DOI 10.1111/hae.14487, PubMed 34994489
39. Koroma AS, Ellie M, Bangura K, Iversen PO, Hendrixson DT, Stephenson K, Manary MJ (2022)
    Supplementary feeding and infection control in pregnant adolescents-A secondary analysis of a randomized trial among malnourished women in Sierra Leone
    Matern Child Nutr, 19 (1), e13456
    DOI 10.1111/mcn.13456, PubMed 36349973
40. Krausz M, Uhlmann A, Rump IC, Ihorst G, Goldacker S, Sogkas G, Posadas-Cantera S, Schmidt R, Feißt M, Alsina L, Dybedal I, Recher M, Warnatz K, Grimbacher B (2022)
    The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial
    Contemp Clin Trials Commun, 30, 101008
    DOI 10.1016/j.conctc.2022.101008, PubMed 36262801
41. Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Osvik Velle E, Skuterud Wik H, Ghanima W, Sandset PM, Dahm AEA (2022)
    Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up
    J Thromb Haemost, 20 (5), 1166-1181
    DOI 10.1111/jth.15666, PubMed 35114046
42. Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2022)
    "Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply
    J Thromb Haemost, 20 (8), 1937-1939
    DOI 10.1111/jth.15774, PubMed 35859282
43. Larsen TL, Ghanima W, Sandset PM, Frøen H, Jacobsen EM, Torfoss D, Dahm AEA (2022)
    [Factor Xa inhibitors in the prevention and treatment of venous thromboembolism in cancer patients]
    Tidsskr Nor Laegeforen, 142 (1)
    DOI 10.4045/tidsskr.22.0228, PubMed 36655971
44. Lehtinen AE, Baghaei F, Astermark J, Holme PA (2022)
    Surgical outcomes in patients with haemophilia A or B receiving extended half-life recombinant factor VIII and IX Fc fusion proteins: Real-world experience in the Nordic countries
    Haemophilia, 28 (5), 713-719
    DOI 10.1111/hae.14585, PubMed 35575446
45. Leleu X, Martin T, Weisel K, Schjesvold F, Iida S, Malavasi F, Manier S, Chang-Ki Min, Ocio EM, Pawlyn C, Perrot A, Quach H, Richter J, Spicka I, Yong K, Richardson PG (2022)
    Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes
    Ann Hematol, 101 (10), 2123-2137
    DOI 10.1007/s00277-022-04917-5, PubMed 35943588
46. Lindahl JP, Barlinn R, Abrahamsen IW, Spetalen S, Midtvedt K, Jenssen T (2022)
    Case Report: Pure Red Cell Aplasia Caused by Refractory Parvovirus B19 Infection After Pancreas Transplantation Alone
    Front Med (Lausanne), 9, 849783
    DOI 10.3389/fmed.2022.849783, PubMed 35372384
47. Massey RJ, Myrdal OH, Diep PP, Burman MM, Brinch L, Gullestad LL, Ruud E, Aakhus S, Beitnes JO (2022)
    Reduced exercise capacity is associated with left ventricular systolic dysfunction in long-term survivors of allogeneic hematopoietic stem-cell transplantation
    J Clin Ultrasound, 51 (1), 5-15
    DOI 10.1002/jcu.23264, PubMed 35788941
48. Matlary RED, Grinda N, Sayers F, Versloot O, McLaughlin P, EAHAD Physiotherapists Committee (2022)
    Promoting physical activity for people with haemophilia in the age of new treatments
    Haemophilia, 28 (6), 885-890
    DOI 10.1111/hae.14641, PubMed 35896000
49. Matlary RED, Holme PA, Glosli H, Rueegg CS, Grydeland M (2022)
    Comparison of free-living physical activity measurements between ActiGraph GT3X-BT and Fitbit Charge 3 in young people with haemophilia
    Haemophilia, 28 (6), e172-e180
    DOI 10.1111/hae.14624, PubMed 35830613
50. McPherson S, Mitchell AK, Sletten I, Kvande ME, Steindal SA (2022)
    Haematological nurses' experiences about palliative care trajectories of patients with life-threatening haematological malignancies: A qualitative study
    Nurs Open, 10 (5), 3094-3103
    DOI 10.1002/nop2.1558, PubMed 36539384
51. Midtvedt Ø, Stray-Pedersen A, Andersson H, Gunnarsson R, Tveten K, Ali MM, Tjønnfjord GE (2022)
    A man in his sixties with chondritis and bone marrow failure
    Tidsskr Nor Laegeforen, 142 (4)
    DOI 10.4045/tidsskr.21.0370, PubMed 35239266
52. Molteberg E, Taubøll E, Kverneland M, Iversen PO, Selmer KK, Nakken KO, Hofoss D, Thorsby PM (2022)
    Substantial early changes in bone and calcium metabolism among adult pharmacoresistant epilepsy patients on a modified Atkins diet
    Epilepsia, 63 (4), 880-891
    DOI 10.1111/epi.17169, PubMed 35092022
53. Muhoozi GKM, Li K, Atukunda P, Skaare AB, Willumsen T, Enersen M, Westerberg AC, Morris A, Vieira AR, Iversen PO, Methé BA (2022)
    Child saliva microbiota and caries: a randomized controlled maternal education trial in rural Uganda
    Sci Rep, 12 (1), 7857
    DOI 10.1038/s41598-022-11979-y, PubMed 35552492
54. Nagler A, Galimard JE, Labopin M, Blaise D, Arcese W, Trisolini SM, Wu D, Pigneux A, Van Gorkom G, Rubio MT, Gedde-Dahl T, Huynh A, Lanza F, Gorin NC, Mohty M (2022)
    Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT
    Cancer Med, 12 (2), 1482-1491
    DOI 10.1002/cam4.5039, PubMed 35891608
55. Nagler A, Labopin M, Craddock C, Socié G, Yakoub-Agha I, Gedde-Dahl T, Niittyvuopio R, Byrne JL, Cornelissen JJ, Labussière-Wallet H, Arcese W, Milpied N, Esteve J, Canaani J, Mohty M (2022)
    Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation
    Am J Hematol, 97 (3), 274-282
    DOI 10.1002/ajh.26442, PubMed 34978724
56. Nagler A, Ngoya M, Galimard JE, Labopin M, Kröger N, Socié G, Gedde-Dahl T, Potter V, Schroeder T, Platzbecker U, Ganser A, Blaise D, Salmenniemi U, Maertens J, Craddock C, Labussière-Wallet H, Yakoub-Agha I, Savani B, Mohty M (2022)
    Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT
    Bone Marrow Transplant, 57 (12), 1788-1796
    DOI 10.1038/s41409-022-01825-0, PubMed 36114249
57. Nagler A, Ngoya M, Galimard JE, Labopin M, Kröger N, Socié G, Gedde-Dahl T, Potter V, Schroeder T, Platzbecker U, Ganser A, Blaise D, Salmenniemi U, Maertens J, Craddock C, Labussière-Wallet H, Yakoub-Agha I, Savani B, Mohty M (2022)
    Correction: Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT
    Bone Marrow Transplant, 57 (12), 1856
    DOI 10.1038/s41409-022-01853-w, PubMed 36280759
58. Nahalomo A, Iversen PO, Andreassen BA, Kaaya AN, Rukooko AB, Rukundo PM (2022)
    Seasonality- and disaster effects on food variety and food insecurity coping strategies among a landslide-prone cohort
    Clin Nutr ESPEN, 52, 229-239
    DOI 10.1016/j.clnesp.2022.11.005, PubMed 36513458
59. Nahalomo A, Iversen PO, Andreassen BA, Kaaya AN, Rukooko AB, Tushabe G, Nateme NC, Rukundo PM (2022)
    Malnutrition and Associated Risk Factors among Children 6-59 Months Old in the Landslide-Prone Bududa District, Eastern Uganda: A Cohort Study
    Curr Dev Nutr, 6 (2), nzac005
    DOI 10.1093/cdn/nzac005, PubMed 35198847
60. Ng S, Rodger MA, Ghanima W, Kovacs MJ, Shivakumar S, Kahn SR, Sandset PM, Kearon C, Mallick R, Delluc A (2022)
    External Validation of the Patient-Reported Villalta Scale for the Diagnosis of Postthrombotic Syndrome
    Thromb Haemost, 122 (8), 1379-1383
    DOI 10.1055/a-1738-1313, PubMed 35021257
61. Ocio EM, Nadeem O, Schjesvold F, Gay F, Touzeau C, Dimopoulos MA, Richardson PG, Mateos MV (2022)
    Melflufen for the treatment of multiple myeloma
    Expert Rev Clin Pharmacol, 15 (4), 371-382
    DOI 10.1080/17512433.2022.2075847, PubMed 35723075
62. Pedersen S, Kverneland M, Nakken KO, Rudi K, Iversen PO, Gervin K, Selmer KK (2022)
    Genome-wide decrease in DNA methylation in adults with epilepsy treated with modified ketogenic diet: A prospective study
    Epilepsia, 63 (9), 2413-2426
    DOI 10.1111/epi.17351, PubMed 35762681
63. Rasmussen B, Göhring G, Bernard E, Nilsson L, Tobiasson M, Jädersten M, Garelius H, Dybedal I, Grønbaek K, Ejerblad E, Lorenz F, Flogegård M, Marcher CW, Öster Fernström A, Cavelier L, Papaemmanuil E, Ebeling F, Kittang AO, Nørgaard JM, Saft L, Möllgård L, Hellström-Lindberg E (2022)
    "Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)"
    Leukemia, 36 (5), 1436-1439
    DOI 10.1038/s41375-022-01537-w, PubMed 35277655
64. Reiter A, Schwaab J, DeAngelo DJ, Gotlib J, Deininger MW, Pettit KM, Alvarez-Twose I, Vannucchi AM, Panse J, Platzbecker U, Hermine O, Dybedal I, Lin HM, Rylova SN, Ehlert K, Dimitrijević S, Radia DH (2022)
    Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis
    Blood Adv, 6 (21), 5750-5762
    DOI 10.1182/bloodadvances.2022007539, PubMed 35640224
65. Rempelos L, Wang J, Barański M, Watson A, Volakakis N, Hadall C, Hasanaliyeva G, Chatzidimitriou E, Magistrali A, Davis H, Vigar V, Średnicka-Tober D, Rushton S, Rosnes KS, Iversen PO, Seal CJ, Leifert C (2022)
    Diet, but not food type, significantly affects micronutrient and toxic metal profiles in urine and/or plasma; a randomized, controlled intervention trial
    Am J Clin Nutr, 116 (5), 1278-1290
    DOI 10.1093/ajcn/nqac233, PubMed 36041176
66. Rempelos L, Wang J, Barański M, Watson A, Volakakis N, Hoppe HW, Kühn-Velten WN, Hadall C, Hasanaliyeva G, Chatzidimitriou E, Magistrali A, Davis H, Vigar V, Średnicka-Tober D, Rushton S, Iversen PO, Seal CJ, Leifert C (2022)
    Diet and food type affect urinary pesticide residue excretion profiles in healthy individuals: results of a randomized controlled dietary intervention trial
    Am J Clin Nutr, 115 (2), 364-377
    DOI 10.1093/ajcn/nqab308, PubMed 34718382
67. Richardson PG, Perrot A, San-Miguel J, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang JS, Minarik J, Cavo M, Prince HM, Malinge L, Dubin F, van de Velde H, Anderson KC (2022)
    Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study
    Lancet Oncol, 23 (3), 416-427
    DOI 10.1016/S1470-2045(22)00019-5, PubMed 35151415
68. Richartz N, Pietka W, Gilljam KM, Skah S, Skålhegg BS, Bhagwat S, Naderi EH, Ruud E, Blomhoff HK (2022)
    cAMP-Mediated Autophagy Promotes Cell Survival via ROS-Induced Activation of PARP1: Implications for Treatment of Acute Lymphoblastic Leukemia
    Mol Cancer Res, 20 (3), 400-411
    DOI 10.1158/1541-7786.MCR-21-0652, PubMed 34880123
69. Røed-Undlien H, Schultz NH, Lunnan A, Husebråten IM, Wollmann BM, Molden E, Bjørnstad JL (2022)
    In Vitro Apixaban Removal By CytoSorb Whole Blood Adsorber: An Experimental Study
    J Cardiothorac Vasc Anesth, 36 (6), 1636-1644
    DOI 10.1053/j.jvca.2022.01.038, PubMed 35272914
70. Schjesvold F, Paiva B, Ribrag V, Rodriguez-Otero P, San-Miguel JF, Robak P, Hansson M, Onishi M, Hamidi H, Malhi V, Dail M, Javery A, Ku G, Raab MS (2022)
    Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple Myeloma
    Clin Lymphoma Myeloma Leuk, 23 (1), e59-e70
    DOI 10.1016/j.clml.2022.10.006, PubMed 36450626
71. Schjesvold F, Richardson PG, Facon T, Alegre A, Spencer A, Jurczyszyn A, Sunami K, Frenzel L, Min CK, Guillonneau S, Lin PL, Le-Guennec S, Campana F, Van de Velde H, Bensfia S, Bringhen S (2022)
    Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis
    Haematologica, 107 (3), 774-775
    DOI 10.3324/haematol.2021.279160, PubMed 35229573
72. Schjesvold FH, Bakker NA, Sonneveld P (2022)
    Melflufen in multiple myeloma: the conclusion matters - Authors' reply
    Lancet Haematol, 9 (4), e244-e245
    DOI 10.1016/S2352-3026(22)00071-0, PubMed 35358436
73. Schjesvold FH, Bakker NA, Sonneveld P (2022)
    Authors' reply: Perspective: The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDA
    Transl Oncol, 25, 101528
    DOI 10.1016/j.tranon.2022.101528, PubMed 36087383
74. Schjesvold FH, Dimopoulos MA, Delimpasi S, Robak P, Coriu D, Legiec W, Pour L, Špička I, Masszi T, Doronin V, Minarik J, Salogub G, Alekseeva Y, Lazzaro A, Maisnar V, Mikala G, Rosiñol L, Liberati AM, Symeonidis A, Moody V, Thuresson M, Byrne C, Harmenberg J, Bakker NA, Hájek R et al. (2022)
    Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study
    Lancet Haematol, 9 (2), e98-e110
    DOI 10.1016/S2352-3026(21)00381-1, PubMed 35032434
75. Schmitz A, Brøndum RF, Johnsen HE, Mellqvist UH, Waage A, Gimsing P, Op Bruinink DH, van der Velden V, van der Holt B, Hansson M, Andersen NF, Frølund UC, Helleberg C, Schjesvold FH, Ahlberg L, Gulbrandsen N, Andreasson B, Lauri B, Haukas E, Bødker JS, Roug AS, Bøgsted M, Severinsen MT, Gregersen H, Abildgaard N et al. (2022)
    Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial
    BMC Cancer, 22 (1), 147
    DOI 10.1186/s12885-022-09184-1, PubMed 35123422
76. Schultz NH, Søraas AVL, Sørvoll IH, Akkök ÇA, Vetlesen A, Bhamra JS, Ahlen MT, Holme PA, Aamodt AH, Skagen K, Skattør TH, Skjelland M, Wiedmann MK (2022)
    Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort study
    J Stroke Cerebrovasc Dis, 32 (1), 106860
    DOI 10.1016/j.jstrokecerebrovasdis.2022.106860, PubMed 36403363
77. Skånland SS, Inngjerdingen M, Bendiksen H, York J, Spetalen S, Munthe LA, Tjønnfjord GE (2022)
    Functional testing of relapsed chronic lymphocytic leukemia guides precision medicine and maps response and resistance mechanisms. An index case
    Haematologica, 107 (8), 1994-1998
    DOI 10.3324/haematol.2021.280393, PubMed 35236056
78. Skånland SS, Tjønnfjord GE (2022)
    Determining drug dose in the era of targeted therapies: playing it (un)safe?
    Blood Cancer J, 12 (8), 123
    DOI 10.1038/s41408-022-00720-7, PubMed 35999205
79. Solhaug TS, Tjønnfjord GE, Bjørgo K, Kildahl-Andersen O (2022)
    A family with cytotoxic T-lymphocyte-associated protein 4 haploinsufficiency presenting with aplastic anaemia
    BMJ Case Rep, 15 (2)
    DOI 10.1136/bcr-2021-247653, PubMed 35228238
80. Stokke C, Nørgaard JN, Feiring Phillips H, Sherwani A, Nuruddin S, Connelly J, Schjesvold F, Revheim ME (2022)
    Comparison of [¹⁸F]fluciclovine and [¹⁸F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
    Mol Imaging Biol, 24 (5), 842-851
    DOI 10.1007/s11307-022-01734-0, PubMed 35501622
81. Strømmen K, Lyche JL, Moltu SJ, Müller MHB, Blakstad EW, Brække K, Sakhi AK, Thomsen C, Nakstad B, Rønnestad AE, Drevon CA, Iversen PO (2022)
    Estimated daily intake of phthalates, parabens, and bisphenol A in hospitalised very low birth weight infants
    Chemosphere, 309 (Pt 1), 136687
    DOI 10.1016/j.chemosphere.2022.136687, PubMed 36206919
82. Swan D, Hayden PJ, Eikema DJ, Koster L, Sauer S, Blaise D, Nicholson E, Rabin N, Touzeau C, Byrne J, Huynh A, Cornelissen JJ, Potter V, Forcade E, Parrish C, Gribben J, Chretien ML, Mielke S, Gedde-Dahl T, Reményi P, Tsirigotis P, Garcia Guiñón A, Beksac M, Schönland S, Yakoub-Agha I (2022)
    Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019
    Br J Haematol, 197 (1), 82-96
    DOI 10.1111/bjh.18025, PubMed 35166376
83. Szanto T, Zetterberg E, Ramström S, Leinøe EB, Holme PA, Antovic JP, Holmström M, Onundarson PT, Pikta M, Vaide I, Olsson A, Magnusson M, Kärkkäinen S, Bitar M, Poulsen LH, Lassila R, Nordic Haemophilia Council (2022)
    Platelet function testing: Current practice among clinical centres in Northern Europe
    Haemophilia, 28 (4), 642-648
    DOI 10.1111/hae.14578, PubMed 35510959
84. Tanem KE, Wilberg P, Diep PP, Ruud E, Skaare AB, Brinch L, Herlofson BB (2022)
    Oral chronic GVHD after allogeneic stem cell transplantation without total body irradiation performed at a young age
    Support Care Cancer, 30 (5), 4121-4128
    DOI 10.1007/s00520-022-06836-7, PubMed 35075489
85. Tarasco E, von Krogh AS, Hrdlickova R, Braschler TR, Iwaniec T, Knöbl PN, Hamada E, Pikovsky O, Farese S, Gutwein O, Kessler P, Schultz NH, von Auer C, Windyga J, Friedman K, Hrachovinova I, George JN, Matsumoto M, Schneppenheim R, Lämmle B, Kremer Hovinga JA (2022)
    Hereditary thrombotic thrombocytopenic purpura and COVID-19: Impacts of vaccination and infection in this rare disease
    Res Pract Thromb Haemost, 6 (7), e12814
    DOI 10.1002/rth2.12814, PubMed 36284639
86. Tavoly M, Asady E, Wik HS, Ghanima W (2022)
    Measuring Quality of Life after Venous Thromboembolism: Who, When, and How?
    Semin Thromb Hemost, 49 (8), 861-866
    DOI 10.1055/s-0042-1754390, PubMed 36055276
87. Tholin B, Fiskvik H, Tveita A, Tsykonova G, Opperud H, Busterud K, Mpinganzima C, Garabet L, Ahmed J, Stavem K, Ghanima W (2022)
    Thromboembolic complications during and after hospitalization for COVID-19: Incidence, risk factors and thromboprophylaxis
    Thromb Update, 6, 100096
    DOI 10.1016/j.tru.2021.100096, PubMed 38620916
88. Toksvang LN, Als-Nielsen B, Bacon C, Bertasiute R, Duarte X, Escherich G, Helgadottir EA, Johannsdottir IR, Jónsson ÓG, Kozlowski P, Langenskjöld C, Lepik K, Niinimäki R, Overgaard UM, Punab M, Räty R, Segers H, van der Sluis I, Smith OP, Strullu M, Vaitkevičienė G, Wik HS, Heyman M, Schmiegelow K (2022)
    Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol
    BMC Cancer, 22 (1), 483
    DOI 10.1186/s12885-022-09522-3, PubMed 35501736
89. Trøseid M, Dahl TB, Holter JC, Kildal AB, Murphy SL, Yang K, Quiles-Jiménez A, Heggelund L, Müller KE, Tveita A, Michelsen AE, Bøe S, Holten AR, Hoel H, Mathiessen A, Aaløkken TM, Fevang B, Granerud BK, Tonby K, Henriksen KN, Lerum TV, Müller F, Skjønsberg OH, Barratt-Due A, Dyrhol-Riise AM et al. (2022)
    Persistent T-cell exhaustion in relation to prolonged pulmonary pathology and death after severe COVID-19: Results from two Norwegian cohort studies
    J Intern Med, 292 (5), 816-828
    DOI 10.1111/joim.13549, PubMed 35982589
90. Tsykunova G, Ghanima W (2022)
    Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives
    Ther Clin Risk Manag, 18, 273-286
    DOI 10.2147/TCRM.S251672, PubMed 35386180
91. Tveita A, Murphy SL, Holter JC, Kildal AB, Michelsen AE, Lerum TV, Kaarbø M, Heggelund L, Holten AR, Finbråten AK, Müller KE, Mathiessen A, Bøe S, Fevang B, Granerud BK, Tonby K, Lind A, Dudman SG, Henriksen KN, Müller F, Skjønsberg OH, Trøseid M, Barratt-Due A, Dyrhol-Riise AM, Aukrust P et al. (2022)
    High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19
    J Infect Dis, 226 (12), 2150-2160
    DOI 10.1093/infdis/jiac313, PubMed 35876699
92. Ueland T, Hausberg I, Mørtberg TV, Dahl TB, Lerum TV, Michelsen A, Ranheim T, Nezvalova Henriksen K, Dyrhol-Riise AM, Holme PA, Aaløkken TM, Skjønsberg OH, Barratt-Due A, Ahlén MT, Aukrust P, Halvorsen B (2022)
    Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology
    Platelets, 33 (4), 640-644
    DOI 10.1080/09537104.2022.2042238, PubMed 35225150
93. Vestad B, Ueland T, Lerum TV, Dahl TB, Holm K, Barratt-Due A, Kåsine T, Dyrhol-Riise AM, Stiksrud B, Tonby K, Hoel H, Olsen IC, Henriksen KN, Tveita A, Manotheepan R, Haugli M, Eiken R, Berg Å, Halvorsen B, Lekva T, Ranheim T, Michelsen AE, Kildal AB, Johannessen A, Thoresen L et al. (2022)
    Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations
    J Intern Med, 291 (6), 801-812
    DOI 10.1111/joim.13458, PubMed 35212063
94. Warlo EMK, Bratseth V, Pettersen AR, Holme PA, Arnesen H, Seljeflot I, Opstad TB (2022)
    Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events
    Clin Appl Thromb Hemost, 28, 10760296221141893
    DOI 10.1177/10760296221141893, PubMed 36474435
95. Wergeland D, Harsten K, Klarare A, Steindal SA (2022)
    Title authors reply to letter to Editor 'Follow-up care after stem-cell transplant'
    J Clin Nurs, 32 (13-14), 4195-4196
    DOI 10.1111/jocn.16436, PubMed 35818338
96. Yin Y, Athanasiadis P, Karlsen L, Urban A, Xu H, Murali I, Fernandes SM, Arribas AJ, Hilli AK, Taskén K, Bertoni F, Mato AR, Normant E, Brown JR, Tjønnfjord GE, Aittokallio T, Skånland SS (2022)
    Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia
    Clin Cancer Res, 28 (20), 4444-4455
    DOI 10.1158/1078-0432.CCR-22-1221, PubMed 35998013
97. Aasebo AT, Gedde-Dahl T, Reims HM, Baekkevold ES, Jahnsen FL (2022)
    Calprotectin Expressing Donor-Derived Macrophages Increase in Acute Gastrointestinal Graft-Versus-Host Disease
    Transplant Cell Ther, 28 (5), 248.e1-248.e8
    DOI 10.1016/j.jtct.2022.01.028, PubMed 35144036

Publications 2021

1. Ahmed J, Stenkula C, Omar S, Ghanima J, Bremtun FF, Bergan J, Raouf N, Ghanima W (2021)
   Patient outcomes after electrical injury - a retrospective study
   Scand J Trauma Resusc Emerg Med, 29 (1), 114
   DOI 10.1186/s13049-021-00920-3, PubMed 34362435
2. Ali M, Giannakopoulou E, Li Y, Lehander M, Virding Culleton S, Yang W, Knetter C, Odabasi MC, Bollineni RC, Yang X, Foldvari Z, Böschen ML, Taraldsrud E, Strønen E, Toebes M, Hillen A, Mazzi S, de Ru AH, Janssen GMC, Kolstad A, Tjønnfjord GE, Lie BA, Griffioen M, Lehmann S, Osnes LT et al. (2021)
   T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes
   Nat Biotechnol, 40 (4), 488-498
   DOI 10.1038/s41587-021-01089-x, PubMed 34873326
3. Ali MM, Grønvold B, Remberger M, Abrahamsen IW, Myhre AE, Tjønnfjord GE, Fløisand Y, Gedde-Dahl T (2021)
   Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival
   Clin Lymphoma Myeloma Leuk, 21 (9), 598-605
   DOI 10.1016/j.clml.2021.05.003, PubMed 34158268
4. Andersen AM, Bergan S, Gedde-Dahl T, Buechner J, Vethe NT (2021)
   Fast and reliable quantification of busulfan in blood plasma using two-channel liquid chromatography tandem mass spectrometry: Validation of assay performance in the presence of drug formulation excipients
   J Pharm Biomed Anal, 203, 114216
   DOI 10.1016/j.jpba.2021.114216, PubMed 34182411
5. Andersen E, Chollet ME, Bernardi F, Branchini A, Baroni M, Mariani G, Dolce A, Batorova A, Skarpen E, Myklebust CF, Skretting G, Sandset PM (2021)
   The Factor VII Variant p.A354V-p.P464Hfs: Clinical versus Intracellular and Biochemical Phenotypes Induced by Chemical Chaperones
   Appl. Sci.-Basel, 11 (13), 5762
   DOI 10.3390/app11135762
6. Andersen E, Chollet ME, Sletten M, Stavik B, Skarpen E, Backe PH, Thiede B, Glosli H, Henriksson CE, Iversen N (2021)
   Molecular Characterization of Two Homozygous Factor VII Variants Associated with Intracranial Bleeding
   Thromb Haemost, 121 (12), 1588-1598
   DOI 10.1055/a-1450-8568, PubMed 33742435
7. Andresen MS, Sletten M, Sandset PM, Iversen N, Stavik B, Tinholt M (2021)
   Coagulation Factor V (F5) is an Estrogen-Responsive Gene in Breast Cancer Cells
   Thromb Haemost, 122 (8), 1288-1295
   DOI 10.1055/a-1707-2130, PubMed 34826880
8. Asady E, Ghanima W, Jelsness-Jorgensen LP, Klok FA, Kahn SR, Stromme H, Wik HS (2021)
   Health-related quality-of-life questionnaires for deep vein thrombosis and pulmonary embolism: A systematic review on questionnaire development and methodology
   Res Pract Thromb Haemost, 5 (5), e12556
   DOI 10.1002/rth2.12556, PubMed 34278190
9. Astermark J, Ay C, Carvalho M, D'Oiron R, Moerloose P, Dolan G, Fontana P, Hermans C, Holme PA, Katsarou O, Kenet G, Klamroth R, Mancuso ME, Marquardt N, Núñez R, Pabinger I, Tait R, Valk PV (2021)
   New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia
   Thromb Haemost, 122 (6), 905-912
   DOI 10.1055/a-1642-4067, PubMed 34507368
10. Atukunda P, Eide WB, Kardel KR, Iversen PO, Westerberg AC (2021)
    Unlocking the potential for achievement of the UN Sustainable Development Goal 2 - 'Zero Hunger' - in Africa: targets, strategies, synergies and challenges
    Food Nutr Res, 65
    DOI 10.29219/fnr.v65.7686, PubMed 34262413
11. Atukunda P, Ngari M, Chen X, Westerberg AC, Iversen PO, Muhoozi G (2021)
    Longitudinal assessments of child growth: A six-year follow-up of a cluster-randomized maternal education trial
    Clin Nutr, 40 (9), 5106-5113
    DOI 10.1016/j.clnu.2021.08.007, PubMed 34461584
12. Barański M, Średnicka-Tober D, Rempelos L, Hasanaliyeva G, Gromadzka-Ostrowska J, Skwarło-Sońta K, Królikowski T, Rembiałkowska E, Hajslova J, Schulzova V, Cakmak I, Ozturk L, Hallmann E, Seal C, Iversen PO, Vigar V, Leifert C (2021)
    Feed Composition Differences Resulting from Organic and Conventional Farming Practices Affect Physiological Parameters in Wistar Rats-Results from a Factorial, Two-Generation Dietary Intervention Trial
    Nutrients, 13 (2)
    DOI 10.3390/nu13020377, PubMed 33530419
13. Bavalia R, Bistervels IM, Boersma WG, Quere I, Brisot D, Falvo N, Stephan D, Couturaud F, Schellong S, Beyer-Westendorf J, Montaclair K, Ghanima W, Ten Wolde M, Coppens M, Ferrari E, Sanchez O, Carroll P, Roy PM, Kahn SR, Meijer K, Birocchi S, Kovacs MJ, Hugman A, Ten Cate H, Wik H et al. (2021)
    Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin
    Res Pract Thromb Haemost, 5 (5), e12566
    DOI 10.1002/rth2.12566, PubMed 34278193
14. Berishvili E, Kaiser L, Cohen M, Berney T, Scholz H, Floisand Y, Mattsson J (2021)
    Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy
    Stem Cell Rev Rep, 17 (1), 63-70
    DOI 10.1007/s12015-020-10004-x, PubMed 32696426
15. Bjørkto MH, Barratt-Due A, Nordøy I, Dörje C, Galteland E, Lind A, Hilli A, Aukrust P, Mjøen G (2021)
    The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report
    BMC Infect Dis, 21 (1), 137
    DOI 10.1186/s12879-021-05789-2, PubMed 33526010
16. Bøhn SK, Thune I, Flote VG, Frydenberg H, Bertheussen GF, Husøy A, Fjeldheim F, Brunvoll SH, Hjartåker A, Mowinckel MC, Sandset PM, Iversen PO (2021)
    Effects of a 1-Year Physical Activity Intervention on Markers of Hemostasis among Breast Cancer Survivors: A Randomized Controlled Trial
    TH Open, 5 (1), e14-e23
    DOI 10.1055/s-0040-1721782, PubMed 33564742
17. Cesaro S, Tridello G, Knelange NS, Blijlevens N, Martin M, Snowden JA, Malladi R, Ljungman P, Deconinck E, Gedde-Dahl T, Byrne J, Xhaard A, Chevallier P, Maertens J, Zuckerman T, Lioure B, Petersen E, Cornelissen JJ, Arcese W, Blaise D, Milpied N, Cahn JY, Aljurf M, de Wreede L, Mauro M et al. (2021)
    Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMT
    Bone Marrow Transplant, 56 (7), 1563-1572
    DOI 10.1038/s41409-021-01212-1, PubMed 33514919
18. Cooper N, Cuker A, Bonner N, Ghanima W, Provan D, Morgan M, Taylor B, D'Alessio D, Arnold D, Viana R (2021)
    Qualitative study to support the content validity of the immune thrombocytopenia (ITP) Life Quality Index (ILQI)
    Br J Haematol, 194 (4), 759-766
    DOI 10.1111/bjh.17694, PubMed 34263940
19. Cui XY, Tjønnfjord GE, Kanse SM, Dahm AEA, Iversen N, Myklebust CF, Sun L, Jiang ZX, Ueland T, Campbell JJ, Ho M, Sandset PM (2021)
    Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia
    Sci Rep, 11 (1), 5127
    DOI 10.1038/s41598-021-84695-8, PubMed 33664415
20. Dahm AEA, Sandset PM (2021)
    Tissue factor pathway inhibitor and bleeding tendency: can hormonal state explain the differences?
    Blood Adv, 5 (11), 2516-2517
    DOI 10.1182/bloodadvances.2021004651, PubMed 34086862
21. Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, Delforge M, Hájek R, Schjesvold F, Cavo M, Goldschmidt H, Facon T, Einsele H, Boccadoro M, San-Miguel J, Sonneveld P, Mey U (2021)
    Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
    Hemasphere, 5 (2), e528
    DOI 10.1097/HS9.0000000000000528, PubMed 33554050
22. Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, Delforge M, Hájek R, Schjesvold F, Cavo M, Goldschmidt H, Facon T, Einsele H, Boccadoro M, San-Miguel J, Sonneveld P, Mey U, EHA Guidelines Committee ESMO Guidelines Committee. Electronic address: guidelines@ehaweb.org (2021)
    Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322]
    Ann Oncol, 33 (1), 117
    DOI 10.1016/j.annonc.2021.10.001, PubMed 34857439
23. Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, Delforge M, Hájek R, Schjesvold F, Cavo M, Goldschmidt H, Facon T, Einsele H, Boccadoro M, San-Miguel J, Sonneveld P, Mey U, EHA Guidelines Committee. Electronic address: guidelines@ehaweb.org, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org (2021)
    Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up^†
    Ann Oncol, 32 (3), 309-322
    DOI 10.1016/j.annonc.2020.11.014, PubMed 33549387
24. Dusingizimana T, Weber JL, Ramilan T, Iversen PO, Brough L (2021)
    A Mixed-Methods Study of Factors Influencing Access to and Use of Micronutrient Powders in Rwanda
    Glob Health Sci Pract, 9 (2), 274-285
    DOI 10.9745/GHSP-D-20-00422, PubMed 34048359
25. Egg D, Rump IC, Mitsuiki N, Rojas-Restrepo J, Maccari ME, Schwab C, Gabrysch A, Warnatz K, Goldacker S, Patiño V, Wolff D, Okada S, Hayakawa S, Shikama Y, Kanda K, Imai K, Sotomatsu M, Kuwashima M, Kamiya T, Morio T, Matsumoto K, Mori T, Yoshimoto Y, Dybedal I, Kanariou M et al. (2021)
    Therapeutic options for CTLA-4 insufficiency
    J Allergy Clin Immunol, 149 (2), 736-746
    DOI 10.1016/j.jaci.2021.04.039, PubMed 34111452
26. Engeseth M, Enden T, Sandset PM, Wik HS (2021)
    Predictors of long-term post-thrombotic syndrome following high proximal deep vein thrombosis: a cross-sectional study
    Thromb J, 19 (1), 3
    DOI 10.1186/s12959-020-00253-8, PubMed 33419441
27. Fernández de Larrea C, Kyle R, Rosiñol L, Paiva B, Engelhardt M, Usmani S, Caers J, Gonsalves W, Schjesvold F, Merlini G, Lentzch S, Ocio E, Garderet L, Moreau P, Sonneveld P, Badros A, Gahrton G, Goldschmidt H, Tuchman S, Einsele H, Durie B, Wirk B, Musto P, Hayden P, Kaiser M et al. (2021)
    Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
    Blood Cancer J, 11 (12), 192
    DOI 10.1038/s41408-021-00587-0, PubMed 34857730
28. Fiskvik H, Jacobsen AF, Iversen N, Henriksson CE, Jacobsen EM (2021)
    Treatment of Homozygous Type II Antithrombin Heparin-Binding Site Deficiency in Pregnancy
    Case Rep Obstet Gynecol, 2021, 4393821
    DOI 10.1155/2021/4393821, PubMed 34513101
29. Flygt H, Söderlund S, Stentoft J, Richter J, Koskenvesa P, Mustjoki S, Majeed W, Lübking A, Dreimane A, Markevärn B, Stenke L, Myhr Eriksson K, Gjertsen BT, Gedde-Dahl T, Dimitrijevic A, Udby L, Olsson-Strömberg U, Hjorth-Hansen H (2021)
    Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study
    Eur J Haematol, 107 (6), 617-623
    DOI 10.1111/ejh.13699, PubMed 34418168
30. Fløisand Y, Schroeder MA, Chevallier P, Selleslag D, Devine S, Renteria AS, Mohty M, Yakoub-Agha I, Chen C, Parfionovas A, Quadri S, Jansson J, Akbari M, Chen YB (2021)
    A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease
    Bone Marrow Transplant, 56 (10), 2477-2488
    DOI 10.1038/s41409-021-01356-0, PubMed 34108672
31. Ghanima W, Gernsheimer T, Kuter DJ (2021)
    How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment
    Blood, 137 (20), 2736-2744
    DOI 10.1182/blood.2021010968, PubMed 33827138
32. Gleditsch J, Jervan Ø, Tavoly M, Geier O, Holst R, Klok FA, Ghanima W, Hopp E (2021)
    Association between myocardial fibrosis, as assessed with cardiac magnetic resonance T1 mapping, and persistent dyspnea after pulmonary embolism
    Int J Cardiol Heart Vasc, 38, 100935
    DOI 10.1016/j.ijcha.2021.100935, PubMed 35005213
33. Gotlib J, Reiter A, Radia DH, Deininger MW, George TI, Panse J, Vannucchi AM, Platzbecker U, Alvarez-Twose I, Mital A, Hermine O, Dybedal I, Hexner EO, Hicks LK, Span L, Mesa R, Bose P, Pettit KM, Heaney ML, Oh ST, Sen J, Lin HM, Mar BG, DeAngelo DJ (2021)
    Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial
    Nat Med, 27 (12), 2192-2199
    DOI 10.1038/s41591-021-01539-8, PubMed 34873345
34. Gregersen H, Peceliunas V, Remes K, Schjesvold F, Abildgaard N, Nahi H, Andersen NF, Vangsted AJ, Klausen TW, Helleberg C, Carlson K, Frølund UC, Axelsson P, Stromberg O, Blimark CH, Crafoord J, Tsykunova G, Eshoj HR, Waage A, Hansson M, Gulbrandsen N (2021)
    Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group
    Eur J Haematol, 108 (1), 34-44
    DOI 10.1111/ejh.13709, PubMed 34536308
35. Grønningsæter IS, Reikvam H, Aasebø E, Bartaula-Brevik S, Hernandez-Valladares M, Selheim F, Berven FS, Tvedt TH, Bruserud Ø, Hatfield KJ (2021)
    Effects of the Autophagy-Inhibiting Agent Chloroquine on Acute Myeloid Leukemia Cells; Characterization of Patient Heterogeneity
    J Pers Med, 11 (8)
    DOI 10.3390/jpm11080779, PubMed 34442423
36. Hasanaliyeva G, Chatzidimitrou E, Wang J, Baranski M, Volakakis N, Pakos P, Seal C, Rosa EAS, Markellou E, Iversen PO, Vigar V, Willson A, Barkla B, Leifert C, Rempelos L (2021)
    Effect of Organic and Conventional Production Methods on Fruit Yield and Nutritional Quality Parameters in Three Traditional Cretan Grape Varieties: Results from a Farm Survey
    Foods, 10 (2)
    DOI 10.3390/foods10020476, PubMed 33671741
37. Holm S, Kared H, Michelsen AE, Kong XY, Dahl TB, Schultz NH, Nyman TA, Fladeby C, Seljeflot I, Ueland T, Stensland M, Mjaaland S, Goll GL, Nissen-Meyer LS, Aukrust P, Skagen K, Gregersen I, Skjelland M, Holme PA, Munthe LA, Halvorsen B (2021)
    Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia
    Eur Heart J, 42 (39), 4064-4072
    DOI 10.1093/eurheartj/ehab506, PubMed 34405870
38. Holstein K, Le Quellec S, Klamroth R, Batorova A, Holme PA, Jiménez-Yuste V, Astermark J (2021)
    Immune tolerance induction in the era of emicizumab - still the first choice for patients with haemophilia A and inhibitors?
    Haemophilia, 28 (2), 215-222
    DOI 10.1111/hae.14470, PubMed 34918839
39. Ihle-Hansen H, Hagberg G, Sandset EC, Ihle-Hansen H, Amundsen EK, Sandset PM, Myrstad M (2021)
    [Anticoagulant reversal in intracerebral haemorrhage]
    Tidsskr Nor Laegeforen, 141 (2021-14)
    DOI 10.4045/tidsskr.21.0063, PubMed 34641660
40. Ihle-Hansen H, Hagberg G, Sandset EC, Ihle-Hansen H, KoldbergAmundsen E, Sandset PM, Myrstad M (2021)
    Reversal of anticoagulant drugs in case of brain haemorrhage
    Tidsskr. Nor. Laegeforen., 141 (14), 1363-1366
41. Iversen PO, Ngari M, Westerberg AC, Muhoozi G, Atukunda P (2021)
    Child stunting concurrent with wasting or being overweight: A 6-y follow up of a randomized maternal education trial in Uganda
    Nutrition, 89, 111281
    DOI 10.1016/j.nut.2021.111281, PubMed 34090214
42. Jacobsen AF, Sandset PM (2021)
    Prior Thromboembolic Disease and Assisted Reproductive Therapy
    Semin Reprod Med, 39 (5-06), 180-185
    DOI 10.1055/s-0041-1732375, PubMed 34261142
43. Jervan Ø, Gleditsch J, Tavoly M, Klok FA, Rashid D, Holst R, Steine K, Stavem K, Ghanima W (2021)
    Pulmonary and cardiac variables associated with persistent dyspnea after pulmonary embolism
    Thromb Res, 201, 90-99
    DOI 10.1016/j.thromres.2021.02.014, PubMed 33662800
44. Jiménez-Yuste V, Rodríguez-Merchán EC, Matsushita T, Holme PA (2021)
    Concomitant use of bypassing agents with emicizumab for people with haemophilia A and inhibitors undergoing surgery
    Haemophilia, 27 (4), 519-530
    DOI 10.1111/hae.14322, PubMed 33988293
45. Johansen S, Laegreid IJ, Ernstsen SL, Azrakhsh NA, Kittang AO, Lindås R, Gjertsen BT, Vetti N, Mørtberg TV, Sørvoll IH, Holme PA, Ahlen MT, Reikvam H (2021)
    Thrombosis and thrombocytopenia after HPV vaccination
    J Thromb Haemost, 20 (3), 700-704
    DOI 10.1111/jth.15604, PubMed 34817130
46. Jørgensen SF, Buechner J, Myhre AE, Galteland E, Spetalen S, Kulseth MA, Sorte HS, Holla ØL, Lundman E, Alme C, Heier I, Flægstad T, Fløisand Y, Benneche A, Fevang B, Aukrust P, Stray-Pedersen A, Gedde-Dahl T, Nordøy I (2021)
    A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT
    J Clin Immunol, 42 (2), 404-420
    DOI 10.1007/s10875-021-01189-y, PubMed 34893945
47. Kaiser M, Beksaç M, Gulbrandsen N, Schjesvold F, Hájek R, Moreau P, de la Fuente FA, Mateos MV, West S, Spencer A, Rajkumar SV, Suryanarayan K, Czorniak M, Li C, Teng Z, Labotka R, Dimopoulos MA (2021)
    Correction to: Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma
    Ann Hematol, 100 (1), 297-302
    DOI 10.1007/s00277-020-04302-0, PubMed 33106909
48. Kakwangire P, Moss C, Matovu N, Atukunda P, Westerberg AC, Iversen PO, Muhoozi G (2021)
    The association between dietary diversity and development among children under 24 months in rural Uganda: analysis of a cluster-randomised maternal education trial
    Public Health Nutr, 24 (13), 4286-4296
    DOI 10.1017/S136898002100077X, PubMed 33706831
49. Katenga-Kaunda LZ, Kamudoni PR, Holmboe-Ottesen G, Fjeld HE, Mdala I, Shi Z, Iversen PO (2021)
    Enhancing nutrition knowledge and dietary diversity among rural pregnant women in Malawi: a randomized controlled trial
    BMC Pregnancy Childbirth, 21 (1), 644
    DOI 10.1186/s12884-021-04117-5, PubMed 34551744
50. Kaufman JL, Gasparetto C, Schjesvold FH, Moreau P, Touzeau C, Facon T, Boise LH, Jiang Y, Yang X, Dunbar F, Vishwamitra D, Unger S, Macartney T, Pesko J, Yu Y, Salem AH, Ross JA, Hong WJ, Maciag PC, Pauff JM, Kumar S (2021)
    Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma
    Am J Hematol, 96 (4), 418-427
    DOI 10.1002/ajh.26083, PubMed 33368455
51. Kharfan-Dabaja MA, Labopin M, Bazarbachi A, Ciceri F, Finke J, Bruno B, Bornhäuser M, Gedde-Dahl T, Labussière-Wallet H, Niittyvuopio R, Valerius T, Angelucci E, Brecht A, Caballero D, Kuball J, Potter V, Schmid C, Tischer J, Zuckerman T, Benedetti F, Blaise D, Diez-Martin JL, Sanz J, Ruggeri A, Brissot E et al. (2021)
    Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT
    Bone Marrow Transplant, 56 (9), 2194-2202
    DOI 10.1038/s41409-021-01317-7, PubMed 33931757
52. Khialani D, Vasan S, Cushman M, Dahm AEA, Sandset PM, Rossouw J, van Hylckama Vlieg A (2021)
    Venous thrombosis with oral postmenopausal hormone therapy: Roles of activated protein C resistance and tissue factor pathway inhibitor
    J Thromb Haemost, 19 (7), 1729-1737
    DOI 10.1111/jth.15319, PubMed 33774921
53. Kihlberg K, Baghaei F, Bruzelius M, Funding E, Andre Holme P, Lassila R, Nummi V, Ranta S, Osooli M, Berntorp E, Astermark J (2021)
    Treatment outcomes in persons with severe haemophilia B in the Nordic region: The B-NORD study
    Haemophilia, 27 (3), 366-374
    DOI 10.1111/hae.14299, PubMed 33780113
54. Kort R, Schlösser J, Vazquez AR, Atukunda P, Muhoozi GKM, Wacoo AP, Sybesma WFH, Westerberg AC, Iversen PO, Schoen ED (2021)
    Model Selection Reveals the Butyrate-Producing Gut Bacterium Coprococcus eutactus as Predictor for Language Development in 3-Year-Old Rural Ugandan Children
    Front Microbiol, 12, 681485
    DOI 10.3389/fmicb.2021.681485, PubMed 34149673
55. Kvam AK, Torp HA, Iversen PO (2021)
    Life-Threatening Acute Chest Syndrome in a Patient With Sickle Cell Disease After Switching From Hydroxyurea Therapy to Partial Exchange Transfusions: A Case Report
    Cureus, 13 (12), e20236
    DOI 10.7759/cureus.20236, PubMed 35004051
56. Lerum TV, Maltzahn NN, Aukrust P, Trøseid M, Henriksen KN, Kåsine T, Dyrhol-Riise AM, Stiksrud B, Haugli M, Blomberg B, Kittang BR, Johannessen A, Hannula R, Aballi S, Kildal AB, Eiken R, Dahl TB, Lund-Johansen F, Müller F, Rodriguez JR, Meltzer C, Einvik G, Ueland T, Olsen IC, NOR-SOLIDARITY Consortium et al. (2021)
    Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9
    Sci Rep, 11 (1), 23205
    DOI 10.1038/s41598-021-02547-x, PubMed 34853380
57. Ludwig H, Sonneveld P, Facon T, San-Miguel J, Avet-Loiseau H, Mohty M, Mateos MV, Moreau P, Cavo M, Pawlyn C, Zweegman S, Engelhardt M, Driessen C, Cook G, Dimopoulos MA, Gay F, Einsele H, Delforge M, Caers J, Weisel K, Jackson G, Garderet L, van de Donk N, Leleu X, Goldschmidt H et al. (2021)
    COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network
    Lancet Haematol, 8 (12), e934-e946
    DOI 10.1016/S2352-3026(21)00278-7, PubMed 34756169
58. Löwenberg B, Pabst T, Maertens J, Gradowska P, Biemond BJ, Spertini O, Vellenga E, Griskevicius L, Tick LW, Jongen-Lavrencic M, van Marwijk Kooy M, Vekemans MC, van der Velden WJFM, Beverloo B, Michaux L, Graux C, Deeren D, de Weerdt O, van Esser JWJ, Bargetzi M, Klein SK, Gadisseur A, Westerweel PE, Veelken H, Gregor M et al. (2021)
    Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial
    Blood Adv, 5 (4), 1110-1121
    DOI 10.1182/bloodadvances.2020003855, PubMed 33616652
59. Małecka A, Trøen G, Delabie J, Małecki J, Østlie I, Tierens A, Randen U, Berentsen S, Tjønnfjord GE (2021)
    The mutational landscape of cold agglutinin disease: CARD11 and CXCR4 mutations are correlated with lower hemoglobin levels
    Am J Hematol, 96 (8), E279-E283
    DOI 10.1002/ajh.26205, PubMed 33891703
60. Martin KA, Beyer-Westendorf J, Davidson BL, Huisman MV, Sandset PM, Moll S (2021)
    Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation
    J Thromb Haemost, 19 (8), 1874-1882
    DOI 10.1111/jth.15358, PubMed 34259389
61. Massey RJ, Diep PP, Burman MM, Kvaslerud AB, Brinch L, Aakhus S, Gullestad L, Ruud E, Beitnes JO (2021)
    Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation
    Open Heart, 8 (2)
    DOI 10.1136/openhrt-2021-001768, PubMed 34933961
62. Melvold K, Giliberto M, Karlsen L, Ayuda-Durán P, Hanes R, Holien T, Enserink J, Brown JR, Tjønnfjord GE, Taskén K, Skånland SS (2021)
    Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B-cell malignancies
    Mol Oncol, 16 (5), 1153-1170
    DOI 10.1002/1878-0261.13153, PubMed 34861096
63. Mirlashari MR, Vetlesen A, Nissen-Meyer LSH, Naper C, Tjønnfjord GE, Njerve IU, Ezligini F, Landmark BF, Meinke S, Sandgren P, Höglund P, Hetland G (2021)
    HLA class I depletion by citric acid, and irradiation of apheresis platelets for transfusion of refractory patients
    Transfusion, 61 (4), 1222-1234
    DOI 10.1111/trf.16282, PubMed 33580979
64. Moreau P, Kumar SK, San Miguel J, Davies F, Zamagni E, Bahlis N, Ludwig H, Mikhael J, Terpos E, Schjesvold F, Martin T, Yong K, Durie BGM, Facon T, Jurczyszyn A, Sidana S, Raje N, van de Donk N, Lonial S, Cavo M, Kristinsson SY, Lentzsch S, Hajek R, Anderson KC, João C et al. (2021)
    Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
    Lancet Oncol, 22 (3), e105-e118
    DOI 10.1016/S1470-2045(20)30756-7, PubMed 33662288
65. Myrdal OH, Aaløkken TM, Diep PP, Ruud E, Brinch L, Fosså K, Mangseth H, Kongerud J, Sikkeland LI, Lund MB (2021)
    Late-Onset, Noninfectious Pulmonary Complications following Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Cohort Study of Long-Term Survivors
    Respiration, 101 (6), 544-552
    DOI 10.1159/000520824, PubMed 34937032
66. Måseide RJ, Berntorp E, Astermark J, Hansen J, Olsson A, Bruzelius M, Frisk T, Aspdahl M, Nummi V, Tjønnfjord GE, Holme PA (2021)
    Haemophilia early arthropathy detection with ultrasound and haemophilia joint health score in the moderate haemophilia (MoHem) study
    Haemophilia, 27 (2), e253-e259
    DOI 10.1111/hae.14245, PubMed 33550602
67. Måseide RJ, Berntorp E, Nummi V, Lassila R, Tjønnfjord GE, Holme PA (2021)
    Bleeding phenotype of patients with moderate haemophilia A and B assessed by thromboelastometry and thrombin generation
    Haemophilia, 27 (5), 793-801
    DOI 10.1111/hae.14355, PubMed 34106506
68. Nagler A, Labopin M, Dholaria B, Wu D, Choi G, Aljurf M, Ciceri F, Gedde-Dahl T, Meijer E, Niittyvuopio R, Bondarenko S, Bourhis JH, Cornelissen JJ, Socié G, Koc Y, Canaani J, Savani B, Bug G, Spyridonidis A, Giebel S, Brissot E, Bazarbachi A, Esteve J, Mohty M (2021)
    Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation
    Transplant Cell Ther, 28 (2), 86.e1-86.e8
    DOI 10.1016/j.jtct.2021.11.013, PubMed 34856420
69. Ngari MM, Obiero C, Mwangome MK, Nyaguara A, Mturi N, Murunga S, Otiende M, Iversen PO, Fegan GW, Walson JL, Berkley JA (2021)
    Mortality during and following hospital admission among school-aged children: a cohort study
    Wellcome Open Res, 5, 234
    DOI 10.12688/wellcomeopenres.16323.2, PubMed 33195820
70. Quiles-Jiménez A, Gregersen I, Segers FM, Skarpengland T, Kroustallaki P, Yang K, Kong XY, Lauritzen KH, Olsen MB, Karlsen TR, Nyman TA, Sagen EL, Bjerkeli V, Suganthan R, Nygård S, Scheffler K, Prins J, Van der Veer E, Øgaard JD, Fløisand Y, Jørgensen HF, Holven KB, Biessen EA, Nilsen H, Dahl TB et al. (2021)
    DNA glycosylase Neil3 regulates vascular smooth muscle cell biology during atherosclerosis development
    Atherosclerosis, 324, 123-132
    DOI 10.1016/j.atherosclerosis.2021.02.023, PubMed 33714552
71. Reding MT, Pabinger I, Holme PA, Poulsen L, Negrier C, Chalasani P, Maas Enriquez M, Wang M, Meijer K, Mancuso ME, Lalezari S (2021)
    Confirmed long-term safety and efficacy of prophylactic treatment with BAY 94-9027 in severe haemophilia A: final results of the PROTECT VIII extension study
    Haemophilia, 27 (3), e347-e356
    DOI 10.1111/hae.14297, PubMed 33818853
72. Reint G, Li Z, Labun K, Keskitalo S, Soppa I, Mamia K, Tolo E, Szymanska M, Meza-Zepeda LA, Lorenz S, Cieslar-Pobuda A, Hu X, Bordin DL, Staerk J, Valen E, Schmierer B, Varjosalo M, Taipale J, Haapaniemi E (2021)
    Rapid genome editing by CRISPR-Cas9-POLD3 fusion
    Elife, 10
    DOI 10.7554/eLife.75415, PubMed 34898428
73. Remberger M, Tjønnfjord GE, Abrahamsen IW, Ali M, Myhre AE, Gedde-Dahl T, Fløisand Y (2021)
    Superior Graft-versus-Host Disease-Free Relapse-Free Survival in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation with Anti-Thymocyte Globulin (ATG) Compared to Matched Related Donor without ATG
    Transplant Cell Ther, 27 (7), 621.e1-621.e3
    DOI 10.1016/j.jtct.2021.03.019, PubMed 33895156
74. Richardson PG, Harrison SJ, Bringhen S, Schjesvold F, Yong K, Campana F, Le-Guennec S, Macé S, Dimopoulos MA (2021)
    Isatuximab for relapsed/refractory multiple myeloma: review of key subgroup analyses from the Phase III ICARIA-MM study
    Future Oncol, 17 (34), 4797-4812
    DOI 10.2217/fon-2021-0568, PubMed 34521277
75. Richardson PG, Schjesvold F, Weisel K, Moreau P, Anderson LD, White D, Rodriguez-Otero P, Sonneveld P, Engelhardt M, Jenner M, Corso A, Dürig J, Pavic M, Salomo M, Beksac M, Oriol A, Lindsay J, Liberati AM, Galli M, Robak P, Larocca A, Yagci M, Vural F, Kanate AS, Jiang R et al. (2021)
    Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics
    Eur J Haematol, 108 (1), 73-83
    DOI 10.1111/ejh.13706, PubMed 34496096
76. Richter J, Lübking A, Söderlund S, Lotfi K, Markevärn B, Själander A, Stenke L, Deneberg S, Ahlstrand E, Myhr-Eriksson K, Panayiotidis P, Gedde-Dahl T, Žáčková D, Mayer J, Olsson-Strömberg U, Mahon FX, Saussele S, Hjorth-Hansen H, Koskenvesa P (2021)
    Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI
    Leukemia, 35 (8), 2416-2418
    DOI 10.1038/s41375-021-01173-w, PubMed 33589755
77. Rørvik SD, Larsen KS, Helgeland L, Dale H, Ivarsen B, Bruserud Ø, Tvedt THA (2021)
    Necrotizing Bacterial Myositis as the Initial Presentation of Severe Aplastic Anaemia
    Case Rep Hematol, 2021, 8276937
    DOI 10.1155/2021/8276937, PubMed 34970463
78. Schjesvold F, Bringhen S, G Richardson P, Perrot A, Leleu X, Moreau P, A Dimopoulos M, Hulin C, Tekle C, Foster MC, Poole EM, van de Velde H, Facon T (2021)
    Isatuximab plus pomalidomide and dexamethasone in frail patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis
    Am J Hematol, 96 (11), E423-E427
    DOI 10.1002/ajh.26319, PubMed 34383345
79. Schjesvold F, Oriol A (2021)
    Current and Novel Alkylators in Multiple Myeloma
    Cancers (Basel), 13 (10)
    DOI 10.3390/cancers13102465, PubMed 34070213
80. Schjesvold FH, Richardson PG, Facon T, Alegre A, Spencer A, Jurczyszyn A, Sunami K, Frenzel L, Min CK, Guillonneau S, Lin PL, Le-Guennec S, Campana F, van de Velde H, Bensfia S, Bringhen S (2021)
    Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis
    Haematologica, 106 (4), 1182-1187
    DOI 10.3324/haematol.2020.253450, PubMed 32586908
81. Schultz NH, Fareed J, Holme PA (2021)
    Investigation of the Optimal Dose aPCC in Reversing the Effect of Factor Xa Inhibitors-An In Vitro Study
    Clin Appl Thromb Hemost, 27, 10760296211021156
    DOI 10.1177/10760296211021156, PubMed 34060371
82. Schultz NH, Glosli H, Bjørnsen S, Holme PA (2021)
    The effect of emicizumab and bypassing agents in patients with hemophilia - An in vitro study
    Res Pract Thromb Haemost, 5 (5), e12561
    DOI 10.1002/rth2.12561, PubMed 34263107
83. Schultz NH, Sørvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, Wiedmann M, Aamodt AH, Skattør TH, Tjønnfjord GE, Holme PA (2021)
    Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
    N Engl J Med, 384 (22), 2124-2130
    DOI 10.1056/NEJMoa2104882, PubMed 33835768
84. Sharma K, Asp NT, Harrison S, Siller R, Baumgarten SF, Gupta S, Chollet ME, Andersen E, Sullivan GJ, Simonsen A (2021)
    Autophagy modulates cell fate decisions during lineage commitment
    Autophagy, 18 (8), 1915-1931
    DOI 10.1080/15548627.2021.2008691, PubMed 34923909
85. Skaarud KJ, Hov JR, Hansen SH, Kummen M, Valeur J, Seljeflot I, Bye A, Paulsen V, Lundin KEA, Trøseid M, Tjønnfjord GE, Iversen PO (2021)
    Mortality and microbial diversity after allogeneic hematopoietic stem cell transplantation: secondary analysis of a randomized nutritional intervention trial
    Sci Rep, 11 (1), 11593
    DOI 10.1038/s41598-021-90976-z, PubMed 34078971
86. Sonneveld P, Dimopoulos MA, Beksac M, van der Holt B, Aquino S, Ludwig H, Zweegman S, Zander T, Zamagni E, Wester R, Hajek R, Pantani L, Dozza L, Gay F, Cafro A, De Rosa L, Morelli A, Gregersen H, Gulbrandsen N, Cornelisse P, Troia R, Oliva S, van de Velden V, Wu K, Ypma PF et al. (2021)
    Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma
    J Clin Oncol, 39 (32), 3613-3622
    DOI 10.1200/JCO.21.01045, PubMed 34520219
87. Steenvoorden L, Bjoernestad EO, Kvesetmoen TA, Gulsvik AK (2021)
    De-labelling penicillin allergy in acutely hospitalized patients: a pilot study
    BMC Infect Dis, 21 (1), 1083
    DOI 10.1186/s12879-021-06794-1, PubMed 34670500
88. Strømmen K, Lyche JL, Moltu SJ, Müller MHB, Blakstad EW, Almaas AN, Sakhi AK, Thomsen C, Nakstad B, Rønnestad AE, Drevon CA, Iversen PO (2021)
    High urinary concentrations of parabens and bisphenol A in very low birth weight infants
    Chemosphere, 271, 129570
    DOI 10.1016/j.chemosphere.2021.129570, PubMed 33453489
89. Strømmen K, Lyche JL, Moltu SJ, Müller MHB, Blakstad EW, Almaas AN, Sakhi AK, Thomsen C, Nakstad B, Rønnestad AE, Drevon CA, Iversen PO (2021)
    Corrigendum to "High urinary concentrations of parabens and bisphenol A in very low birth weight infants" [Chemosphere 271 (2021) 129570]
    Chemosphere, 275, 130613
    DOI 10.1016/j.chemosphere.2021.130613, PubMed 33931266
90. Tangen JM (2021)
    We are star dust. Nuclear physics for most people
    Tidsskr. Nor. Laegeforen., 141 (2), 178
91. Terpos E, Zamagni E, Lentzsch S, Drake MT, García-Sanz R, Abildgaard N, Ntanasis-Stathopoulos I, Schjesvold F, de la Rubia J, Kyriakou C, Hillengass J, Zweegman S, Cavo M, Moreau P, San-Miguel J, Dimopoulos MA, Munshi N, Durie BGM, Raje N, Bone Working Group of the International Myeloma Working Group (2021)
    Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group
    Lancet Oncol, 22 (3), e119-e130
    DOI 10.1016/S1470-2045(20)30559-3, PubMed 33545067
92. Tholin B, Ghanima W, Einvik G, Aarli B, Brønstad E, Skjønsberg OH, Stavem K (2021)
    Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis
    Br J Haematol, 194 (3), 542-546
    DOI 10.1111/bjh.17522, PubMed 34028814
93. Tjonnfjord GE, Schjesvold FH, Gulbrandsen N, Kvam AK (2021)
    Monoclonal gammopathy of clinical importance
    Tidsskr. Nor. Laegeforen., 141 (13), 1276-1280
94. Tjønnfjord E, Moe RB, Ghanima W, Aballi S (2021)
    Subacute thyroiditis after COVID-19
    Tidsskr Nor Laegeforen, 141 (10)
    DOI 10.4045/tidsskr.21.0169, PubMed 34182720
95. Tjønnfjord GE, Schjesvold FH, Gulbrandsen N, Kvam AK (2021)
    [Monoclonal gammopathy of clinical importance]
    Tidsskr Nor Laegeforen, 141 (2021-13)
    DOI 10.4045/tidsskr.20.0981, PubMed 34596996
96. Tjønnfjord SKV, Tjønnfjord EB, Konopski Z, Tjønnfjord GE (2021)
    Successful Control of Hepatitis B Virus Reactivation following Restart of Ibrutinib in Chronic Lymphocytic Leukaemia
    Case Rep Hematol, 2021, 1862446
    DOI 10.1155/2021/1862446, PubMed 34721911
97. Tvedt THA, Steien E, Øvrebø B, Haaverstad R, Hobbs W, Wardęcki M, Tjønnfjord GE, Berentsen SA (2021)
    Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery
    Am J Hematol, 97 (2), E51-E54
    DOI 10.1002/ajh.26409, PubMed 34778998
98. Tvedt THA, Vo AK, Bruserud Ø, Reikvam H (2021)
    Cytokine Release Syndrome in the Immunotherapy of Hematological Malignancies: The Biology behind and Possible Clinical Consequences
    J Clin Med, 10 (21)
    DOI 10.3390/jcm10215190, PubMed 34768710
99. van Dam LF, Dronkers CEA, Gautam G, Eckerbom Å, Ghanima W, Gleditsch J, van Haren GR, von Heijne A, Huisman MV, Stöger JL, Westerlund E, Kroft LJM, Klok FA (2021)
    Detection of upper extremity deep vein thrombosis by magnetic resonance non-contrast thrombus imaging
    J Thromb Haemost, 19 (8), 1973-1980
    DOI 10.1111/jth.15394, PubMed 34018662
100. Violette PD, Cartwright R, Devereaux PJ, Gross PL, Kaukonen KM, Sandset PM, Kilpeläinen TP, Lavikainen LI, Sallinen V, Horstia S, Guyatt GH, Tikkinen KAO (2021)
     ARTS: A Large, International Trial of Thromboprophylaxis in Intra-abdominal, Gynecologic, and Urologic Surgery
     Eur Urol Focus, 7 (6), 1222-1225
     DOI 10.1016/j.euf.2021.08.010, PubMed 34556452
101. Waidhauser J, Labopin M, Esteve J, Kröger N, Cornelissen J, Gedde-Dahl T, Van Gorkom G, Finke J, Rovira M, Schaap N, Petersen E, Beelen D, Bunjes D, Savani B, Schmid C, Nagler A, Mohty M, Acute Leukemia Working Party of EBMT (2021)
     Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT
     Bone Marrow Transplant, 56 (10), 2445-2453
     DOI 10.1038/s41409-021-01322-w, PubMed 34059800
102. Walladbegi J, Henriksson R, Tavelin B, Svanberg A, Larfors G, Jädersten M, Schjesvold F, Mahdi A, Garming Legert K, Peterson DE, Jontell M (2021)
     Efficacy of a novel device for cryoprevention of oral mucositis: a randomized, blinded, multicenter, parallel group, phase 3 trial
     Bone Marrow Transplant, 57 (2), 191-197
     DOI 10.1038/s41409-021-01512-6, PubMed 34728786
103. Wang J, Barański M, Hasanaliyeva G, Korkut R, Kalee HA, Leifert A, Winter S, Janovska D, Willson A, Barkla B, Iversen PO, Seal C, Bilsborrow P, Leifert C, Rempelos L, Volakakis N (2021)
     Effect of irrigation, fertiliser type and variety on grain yield and nutritional quality of spelt wheat (Triticum spelta) grown under semi-arid conditions
     Food Chem, 358, 129826
     DOI 10.1016/j.foodchem.2021.129826, PubMed 33933964
104. Wedge E, Hansen JW, Dybedal I, Creignou M, Ejerblad E, Lorenz F, Werlenius O, Ungerstedt J, Holm MS, Nilsson L, Kittang AO, Antunovic P, Rohon P, Andersen MK, Papaemmanuil E, Bernard E, Jädersten M, Hellström-Lindberg E, Grønbæk K, Ljungman P, Friis LS (2021)
     Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: Clinical and Molecular Genetic Prognostic Factors in a Nordic Population
     Transplant Cell Ther, 27 (12), 991.e1-991.e9
     DOI 10.1016/j.jtct.2021.08.028, PubMed 34500124
105. Wergeland D, Harsten K, Klarare A, Steindal SA (2021)
     Hospital nurses' experiences of assessing health status changes in stem-cell transplanted patients in home care: A qualitative study
     J Clin Nurs, 31 (21-22), 3190-3199
     DOI 10.1111/jocn.16155, PubMed 34837292
106. Wiedmann M, Skattør T, Stray-Pedersen A, Romundstad L, Antal EA, Marthinsen PB, Sørvoll IH, Leiknes Ernstsen S, Lund CG, Holme PA, Johansen TO, Brunborg C, Aamodt AH, Schultz NH, Skagen K, Skjelland M (2021)
     Vaccine Induced Immune Thrombotic Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High Fatality Rate: A Case Series
     Front Neurol, 12, 721146
     DOI 10.3389/fneur.2021.721146, PubMed 34393988
107. Wik HS, Kahn SR, Eriksson H, Morrison D, Ghanima W, Schulman S, Sandset PM (2021)
     Post-thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long-term cross-sectional follow-up of RE-COVER study patients
     J Thromb Haemost, 19 (10), 2495-2503
     DOI 10.1111/jth.15449, PubMed 34255420
108. Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JM, Musso M, Giebel S, Uzay A, Langmuir P, Hollaender N, Gowda M, Stefanelli T, Lee SJ, Teshima T, Locatelli F, REACH3 Investigators (2021)
     Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
     N Engl J Med, 385 (3), 228-238
     DOI 10.1056/NEJMoa2033122, PubMed 34260836